Regulation of Gastrointestinal Smooth Muscle Function by Hydrogen Sulfide by Nalli, Ancy
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2013
Regulation of Gastrointestinal Smooth Muscle
Function by Hydrogen Sulfide
Ancy Nalli
Virginia Commonwealth University
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Physiology Commons
© The Author
This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses
and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/3126
1 
 
Regulation of Gastrointestinal Smooth Muscle Function by 
Hydrogen Sulfide 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Science 
at Virginia Commonwealth University 
By 
Ancy Dimpy Nalli 
Bachelor of Science in Biotechnology, Osmania University, 2011 
 
 
Director 
S. Murthy Karnam, Ph.D. 
Department of Physiology and Biophysics  
 
Virginia Commonwealth University 
Richmond, Virginia 
April 2013 
2 
 
ACKNOWLEDGEMENTS 
It is with immense gratitude that I acknowledge the support and help of my mentor, Dr Karnam 
S. Murthy throughout the course of this work. I am extremely thankful for the quality of training 
and direction I have received under him for it is his sheer genius that has molded me into the 
student that I am today. I will ever be indebted to him for teaching me the critical aspects of 
science, for bearing with me through my mistakes and for always being a constant counsel all 
through my work in his lab.  
I would like to express my sincere gratitude to Dr. John R. Grider for his guidance and advice on 
different aspects of my project. His wholesome perspective of research has helped me learn and 
appreciate the finer attributes of science.  
I am very grateful to my Graduate Advisory Committee, Dr. Murthy, Dr. Grider and Dr. Phillip 
B. Hylemon for their valuable suggestions and constructive assessment of my work. Their 
support and encouragement has been a key incentive to set realistic aims and to pursue results. I 
thank them for their time and advice all through my project. I would also like to thank my 
program director, Dr. Gail E. Christie, for accepting me into the program and for guiding me at 
every step of my graduate study.  
 I am extremely thankful to Dr. Rajagopal and Dr. Mahavadi for teaching the basics of 
experimental techniques, for their corrections and their help in troubleshooting with the 
experiments. Most of all, I appreciate their patience with me in allowing me to learn through my 
mistakes and teaching me to be a better technician. This work would have been incomplete 
without the members of the GI lab, who have been my family over the past 2 years. I have never 
felt more welcome as I have felt in the VPENS (VCU Program in Enteric Neuromuscular 
3 
 
Sciences) division. I would like to thank my family and friends for always being there and for 
seeing me through the duration of my study at VCU.  Most importantly, God is the wind under 
my wings.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
 
LIST OF FIGURES 
I. Expression of CSE in smooth muscle cells……………………………………………….42 
II. Effect of L-Cysteine on carbachol-induced contraction in gastric muscle strips……........44 
III. Effect of NaHS on carbachol-induced contraction in gastric muscle strips………………46 
IV. Effect of L-cysteine and NaHS on carbachol-induced contraction in isolated muscle cells 
of stomach………………………………………………………………………………...48 
V. Effect of L-cysteine on carbachol-induced contraction in isolated muscle cells of 
stomach…………………………………………………………………………………....50 
VI. Effect of NaHS on carbachol-induced contraction in isolated muscle cells of stomach….52 
VII. Effect of glibenclamide on relaxation induced by L-cysteine and NaHS in isolated muscle 
cells of stomach…………………………………………………………………………...54 
VIII. Effect of glibenclamide on relaxation induced by levcromakalin in isolated muscle cells of 
stomach …………………………………………………………………………………...56 
IX. Effect of H-89 and Rp-cGMPS on relaxation induced by L-cysteine and NaHS in isolated 
muscle cells of stomach…………………………………………………………………...58 
X. Effect of H-89 and Rp-cGMPS on relaxation induced by forskolin and S-
nitrosoglutathione, respectively, in isolated muscle cells of stomach……………………60 
XI. Effect of L-cysteine and NaHS on adenylyl cyclase activity in isolated muscle cells of 
stomach……………………………………………………………………………………62 
XII. Effect of Rho kinase inhibitor in carbachol-induced sustained contraction………………64 
XIII. Effect of L-cysteine and NaHS on carbachol-stimulated Rho kinase activity in isolated 
muscle cells of stomach…………………………………………………………………...66 
5 
 
XIV. Effect of CSE siRNA on L-cysteine-induced inhibition of Rho kinase activity………….68 
XV. Scheme depicting pathways involved in regulation of MLC20 phosphorylation and muscle 
contraction in smooth muscle…………………………………………………..…………76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
TABLE OF CONTENTS 
Acknowledgements……………………………………………………………………………….2 
List of figures……………………………………………………………………………………...4 
Abstract……………………………………………………………………………………………7 
Chapter A- INTRODUCTION 
1. Production and Metabolism of Hydrogen Sulphide in mammalian cells………………..11 
2. Catabolism of Hydrogen Sulphide……………………………………………………….15 
3. Physiological effects of Hydrogen Sulphide……………………………………………..16 
4. Molecular mechanisms of Hydrogen Sulphide…………………………………………..20 
5. Hydrogen Sulphide in the Gastrointestinal System……………………………………...21 
6. Gastric Motility…………………………………………………………………………..22 
 
Chapter B- MATERIALS AND METHODS 
1. Reagents………………………………………………………………………………….27 
2. Animals…………………………………………………………………………………..27 
3. Preparation of dispersed smooth muscle cells…………………………………………...28 
4. Preparation of cultured smooth muscle cells…………………………………………….28 
5. RT-PCR analysis of CBS and CSE………………………………………………………29 
6. Western blot analysis of CBS and CSE………………………………………………….29 
7. Transfection of CSE siRNA in cultured gastric cells……………………………………30 
8. Measurement of Adenylyl cyclase activity………………………………………………30 
9. Assay for Rho-kinase activity……………………………………………………………31 
7 
 
10. Measurement of contraction and relaxation of muscle strips……………………………32 
11. Measurement of contraction and relaxation in freshly isolated muscle cells……………32 
12. Statistical Analysis………………………………………………………………………33 
 
Chapter C- RESULTS 
1. Expression of CSE in smooth muscle cells from stomach………………………………34 
2. Inhibition of contraction by H2S in muscle strips………………………………………..35 
3. Inhibition of contraction by H2S in isolated muscle cells………………………………..36 
4. Mechanism of action of H2S to mediate relaxation  
a. Effect of H2S on cAMP levels in isolated muscle cells from stomach………………37 
b. Inhibition of Rho kinase activity by H2S in muscle cells……………………………38 
c. Inhibition of Rho kinase activity by L-Cysteine is mediated via CSE/ H2S…………39 
 
Chapter D- DISCUSSION……………………………………………………………………….69 
Chapter E- BIBLIOGRAPHY…………………………………………………………………...77 
Vita……………………………………………………………………………………………….90 
 
 
 
 
 
 
8 
 
ABSTRACT 
Inhibitory neurotransmitters, chiefly nitric oxide and vasoactive intestinal peptide, cause MLC20 
dephosphorylation and muscle relaxation via inhibition of myosin light chain (MLC) kinase and 
activation of MLC phosphatase.  Hydrogen sulfide (H2S) produced as a byproduct by luminal 
sulfate-reducing commensal bacteria or as an endogenous signaling molecule synthesized from 
L-cysteine via cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS) regulates muscle 
contraction.  However, the role of H2S in the regulation of MLC phosphatase activity and MLC20 
phosphorylation is not known.  The aim of the present study was to examine the expression of 
CSE and CBS in smooth muscle cells and to elucidate the molecular mechanism of H2S-induced 
muscle relaxation.  Expression of CSE and CBS was determined by RT-PCR and western blot in 
muscle cells.  The effect of H2S on CCh-stimulated RhoA/Rho kinase pathway and muscle 
contraction was examined using an endogenous activator of CSE (L-cysteine) and an exogenous 
H2S donor (NaHS).  Isometric contraction in isolated muscle strips and scanning micrometry in 
isolated muscle cells was measured.  Rho kinase activity was measured by immunokinase assay.  
Expression of CSE, but not CBS was detected in smooth muscle cells of stomach and colon from 
mouse, rabbit and human. Carbachol-induced contraction in muscle strips and in freshly 
dispersed muscle cells was inhibited by L-cysteine and NaHS in a concentration-dependent 
manner (1 to 100 mM).  Glibenclamide, an inhibitor of KATP channels and a known target of 
H2S, had no effect on the inhibition of contraction by H2S.  L-cysteine (10 mM) or NaHS (1 
mM) inhibited carbachol-induced Rho kinase activity, and the inhibition by L-cysteine was 
blocked in cells transfected with CSE-specific siRNA.  We conclude that both endogenous and 
exogenous H2S induce muscle relaxation, and the mechanism is inhibition of RhoA/Rho kinase 
activity and stimulation of MLCP activity leading to MLC20 dephosphorylation. 
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A. INTRODUCTION 
     H2S is a colorless and flammable gas with a molecular weight of 34.08 and a vapor 
density (d) of 1.19, heavier than air (d=1.0).  Its smell is characteristic of rotten eggs or the 
obnoxious odor of a blocked sewer. Its boiling point is -60.3°C, melting point is -82.3°C, and 
freezing point is -86°C.  H2S is the sulfur analog of water molecule and can be oxidized in a 
series of reactions to form sulfur dioxide (SO2), sulfates such as sulfuric acid, and elemental 
sulfur. 
The important life-supporting role of hydrogen sulfide (H2S) has evolved from bacteria to 
plants, invertebrates, vertebrates, and finally to mammals.  Over the years, H2S had only been 
known for its toxicity and environmental hazard.1 It has caused life destructions and extinctions 
on the earth over centuries. H2S was believed to be the root cause for multiple mass extinctions 
on earth, with one of the most significant in the end of Permian period.2 Since the first 
description of the toxicity of H2S in 1713, most studies about H2S have been devoted to its toxic 
effects.  H2S may be released either from inorganic sulfur compound or has its bacterial sources.3 
Some anaerobic organisms called green sulfur bacteria (Chlorobium) use sulfate dissolved in 
ocean water for respiration instead of oxygen, and subsequently produce H2S.2  
Plants are the primary producers of organic sulfur compounds and can couple 
photosynthesis to the reduction of sulfate, assimilation into cysteine, and further metabolism into 
methionine, glutathione, and many other compounds.4 They can incorporate inorganic sulfate, 
which is reduced to sulfide and is then incorporated into cysteine. Anionic sulfate, which is 
relatively abundant in the environment, is the primary sulfur source for plants. After being 
transported into roots, sulfate may remain in the roots or be distributed to other parts. The 
transportation into cells is mediated by plasma membrane-localized hydrogen/sulfate 
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cotransporters, driven by the electrochemical gradient established by the plasma membrane 
proton ATPase. Certain plants can process sulfate ion from the soil and convert it into plant 
protein. Subsequent decomposition of these plant proteins lead to the release of H2S. This 
process also involves a wide variety of actinomycetes, fungi, and the bacteria heterotrophy 
Proteus vulgaris. Among those life forms that share the H2S-producing ability with bacteria and 
plants are invertebrates. Tissue homogenates of Manila clam Tapes philippinarum and the 
lugworm Arenicola marina produce significant quantities of H2S gas.5  The worm Urechis caupo 
Fisher also produces H2S.6  
Significant levels of H2S were detected in mammalian tissues from human, rat and cow in 
the range of 50- 160 mM.7 Animals have a dietary requirement for sulfur amino acids. Cysteine is 
the central intermediate component from which most sulfur compounds are synthesized. The 
enzymatic mechanisms for endogenous production of H2S in mammals were also known to be 
mostly composed of cystathionine-b-synthase (CBS)8 9 10 cystathionine-g-lyase (CSE)11 12 13 and 
3-mercaptopyruvate sulfurtransferase (MST).14 15 It was seen that sodium hydrogen sulfide 
(NaHS), a donor of H2S, augmented sodium nitroprusside-induced relaxation of guinea pig 
ileum.16 It also reversed the spasmolytic effects of azide and hydroxylamine on rabbit aortic 
strips. In vitro studies revealed that NaHS at toxicologically relevant concentrations had complex 
effects on electrophysiology properties of neuronal membrane and an array of K+ conductance17. 
H2S donor, NaHS, facilitated the induction of hippocampal long-term potentiation (LTP) at 
micromolar concentrations.18 This effect is beneficial, away from the conventionally assumed 
toxic image of H2S. The expression of CBS mRNA was then confirmed in the hippocampus 
using Northern blot. Although it was not known by then whether altering endogenous H2S level 
affects the LTP process, H2S was labeled a “neuromodulator” in the brain. The similar approach 
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was employed to show H2S was produced in vascular tissues and induced vasorelaxation.19 It 
was demonstrated that both the expression and activity of CSE can be upregulated by Nitric 
oxide (NO), leading to increased production of H2S from vascular smooth muscle cells 
(SMCs).20 Unlike NO that relaxes blood vessel walls by activating guanylyl cyclase to release 
cGMP, the specific molecular targets of H2S in vascular SMCs are KATP channels. This is the 
first molecule target of H2S identified in the cardiovascular system. By stimulating KATP 
channels, H2S causes vasorelaxation within a physiologically relevant concentration range. 
 
A1.  Production and metabolism of Hydrogen Sulfide in mammalian cells 
 
H2S is generated in mammalian cells via both enzymatic and nonenzymatic pathways, 
although the nonenzymatic pathway only accounts for a small portion of H2S production. Among 
enzymes involved in H2S production, CBS and CSE have been extensively studied. Both the 
enzymes use pyridoxal 5’-phosphate (vitamin B6) as a cofactor. MST along with cysteine 
aminotransferase (CAT) regulates endogenous H2S level in specific types of cells and tissues. 
These enzymes are involved in transsulfuration and reverse transsulfuration pathways in 
different capacities and utilize specific substrates.  
Cystathionine-b-synthase(CBS). In the presence of cysteine, more so in the presence of 
homocysteine, CBS catalyzes the production of H2S. The most well-known reaction catalyzed by 
CBS is the condensation of homocysteine and serine: L serine + L-homocysteine=L-
cystathionine + H2O. This is the first significant step in the biosynthesis of cysteine from 
methionine by reverse transsulfuration. CBS catalyzes the condensation of cysteine with 
homocysteine to form cystathionine and H2S.21 Binding of the allosteric activator, S-adenosyl-L-
methionine (AdoMet or SAM), to the COOH domain of CBS causes a conformational change 
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which activates CBS. SAM is a common cosubstrate involved in methyl group transfers, 
transmethylation, transsulfuration, and aminopropylation pathways, and is mostly produced in 
liver.22 Deletion of the regulatory domain also can constitutively activate CBS.23 This regulatory 
domain is important for maintaining the tetrameric state of the protein.24 The calmodulin binding 
consensus sequence (19 amino acids) has also been identified in CBS at its COOH terminal 
domain. After calcium-activated calmodulin binds to this consensus sequence, the catalytic 
domain of CBS opens up and the enzyme becomes active. 
CBS expression is significant in the brain is the primary enzyme that catalyzes the 
production of H2S in the central nervous system. CBS was found to be highly expressed in the 
hippocampus and cerebellum when compared with the cerebral cortex and brain stem.25  In other 
tissues, such as cardiovascular system, respiratory system, testes, adrenal, and spleen from rats, 
mice or humans, CBS expression is rare or absent.26 In the absence of CBS, these tissues will not 
be able to catabolize homocysteine via transsulfuration pathway and therefore become 
hypersensitive to homocysteine toxicity.27 Another consequence for this lack of CBS is that these 
tissues would rely on extracellular supply of cysteine due to the deficiency in cysteine synthesis. 
Mutations of the regulatory domain of CBS may lead to alterations in the constitutive activation 
of this enzyme, leading to hereditary diseases such as in homocystinuric patients.28 At least 153 
mutations in human CBS gene have been identified in patients with homocystinuria,29 
characterized by an accumulation of homocysteine in the serum and urine. Both gain-of-function 
polymorphisms and loss-of-function polymorphism have been identified with the CBS gene. 
Apart from production by CBS, H2S production in the brain is partly regulated by 
testosterone and SAM.30 Male brains contain more H2S than female brains at each age, 
suggesting the involvement of testosterone in the regulation of the H2S level. Glucocorticoids 
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also stimulate CBS gene expression.31 CBS expression is also upregulated by epidermal growth 
factor (EGF), transforming growth factor-b (TGF-b), cAMP, and dexamethasone in reactive 
astrocytes.32  
Cystathionine-g-lyase(CSE). Cystathionine-g-lyase has been conventionally abbreviated 
as CSE, CGL, or CTH. CSE has been described as a beta-replacing lyase with a strict specificity 
for the primary substrate L-cysteine and for several sulfur-containing co-substrates.33 34 Unlike 
CBS which is expressed in the central nervous system, CSE is expressed abundantly in 
mammalian cardiovascular system and respiratory system.35 It appears to be the main H2S 
producing enzyme in the liver, kidney, uterus, placenta, as well as pancreatic islets.36 Low levels 
of CSE are also detectable in the small intestine and stomach of rodents.37 Small amounts of CSE 
mRNA have also been detected in the brain.38 CSE is capable of using L-cysteine as the substrate 
to form two gases, H2S and NH3, and pyruvate.39 
The levels of H2S in vascular tissues are affected by NO through two different 
mechanisms. NO increases CSE activity in vascular tissues.40 Rat aortic tissue homogenate, 
when incubated with a NO donor for 90 min, significantly increased H2S generation in a 
concentration-dependent manner. One possibility is that NO increases the activity of cGMP-
dependent protein kinase (PKG), which in turn stimulates CSE. Alternatively, NO may directly 
act on CSE protein. The second mechanism for NO-induced H2S production is the upregulation 
of CSE expression. CSE can be upregulated by bacterial endotoxin41 as well as during liver 
regeneration.42  CSE is reported to be repressed during a viral infection in humans due to 
immunodeficiency. Some studies show that CSE is significantly unregulated in rats during the 
lactation period.43 CSE transcription and protein turnover rates are also affected by vitamin B6 
availability.44 Stimulation of endothelial cells with vascular endothelial growth factor (VEGF) 
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upregulates CSE and increases H2S release.45 Testosterone is another endogenous CSE 
stimulator. It does not change the expression of CSE but stimulates CSE activity.46  
Human deficiency of CSE may lead to a metabolic disorder named cystathioninuria that is 
inherited in an autosomal recessive manner. In patients with Cystathionuria, an excess of 
cystathionine is reported in the urine. Other diseases related to CSE mutation include 
hypercystathioninemia and increase the risk of developing atherosclerosis and bladder cancer.47  
MST and CAT. MST (or SseA) is synonymous with b-mercaptopyruvate 
sulfurtransferase. MST has A and B chains. MST is involved in cyanide detoxification as MST 
transfers the sulfane sulfur from substrate to cyanide ion, giving nontoxic thiocyanate and 
pyruvate. The first crystal structure of MST was derived from Escherichia coli. 48 The cofactor 
of MST is zinc. Another enzyme that has been reported to generate H2S in rat liver is CAT.49 
CAT, otherwise known as cysteine aminotransferase also uses PLP (pyridoxal 5-phosphate) as 
the cofactor. MST and CAT are localized in both cytosol and mitochondria. MST generates H2S 
in the presence of CAT and cofactors 2-oxoglutarate and PLP.50 CAT converts cysteine to 3-
mercaptopyruvate (3-MP). MST then transfers the sulfur from 3-MP to sulfite or other sulfur 
acceptors or form elemental sulfur. The direct outcome of the CAT-MST pathway is the 
production of sulfane sulfur (or bound sulfur). H2S would be consequently formed either through 
reduction of the atomic sulfur or released from thiosulfate or persulfides. 
Transsulfuration and reverse transsulfuration are two opposite processes involving the 
interconversion between the sulfur-containing amino acids cysteine and methionine. Reverse 
transsulfuration occurs in vertebrates and fungi with the final product being cysteine.51 
Transsulfuration is the transformation of cysteine into homocysteine via the intermediate L-
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cystathionine with the final product being methionine. This occurs mainly in bacteria, fungi, and 
plants.  
 
A2. Catabolism of Hydrogen Sulfide 
A significant amount of exhaled H2S has been measured after intravenous administration of 
sodium sulfide.52 An increased amount of exhaled H2S has also been reported after inhibition of 
endogenous NO synthesis. The endogenous polysulfide DADS (diallyl disulfide) increases the 
amount of H2S exhaled, as DADS act as H2S donors when they react with biological thiols such 
as GSH. H2S is also excreted in the urine primarily as sulfate (either free sulfate or thiosulfate) 
and in feces and flatus unchanged as free sulfide.  
In the mitochondria, H2S is first oxidized to thiosulfate and then to sulfite and sulfate.53 
The formation of thiosulfate is not enzymatic, but thiosulfate conversion to sulfite and/or sulfate 
is catalyzed by sulfide-detoxifying enzymes. Rhodanese is a sulfide-detoxifying enzyme.54 
Methylation is another catabolic pathway for H2S. While the oxidation of H2S occurs mainly in 
mitochondria, methylation mainly takes place in the cytosol.  
The methylation of H2S yields methanethiol (CH3SH). H2S has been reported to be 
methylated to methanethiol in vitro by the intestinal mucosa of Sprague-Dawley rats. The 
enzyme Thiol-S-Methyltransferase (TSMT) methylates H2S into methanethiol and 
dimethylsulfide. TSMT is a ubiquitous enzyme with the highest activity in the colonic and cecal 
mucosa,55 but its activity has also been reported in the liver, lung, and kidney. Compared with 
sulfide oxidation, sulfide methylation is slow. H2S can also be scavenged by metallo- or 
disulfide-containing molecules such as horseradish peroxidise, catalase, and oxidized 
glutathione.56  
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A3. Physiological effects of Hydrogen Sulphide 
 H2S has several features in common with the other two well known “gasotransmitters” 
(nitric oxide and carbon monoxide) in the biological systems.57 Like H2S, both nitric oxide (NO) 
and Carbon monoxide (CO) are colorless gases and easily penetrate the biological membrane. 
NO is a free radical and produces the extremely toxic hydroxyl radical when it combines with 
superoxide. CO is a reducing agent like H2S. With these differences and similarities, H2S, NO, 
and CO elicit several effects; some of them are opposite, whereas others are quite similar.58  
H2S as a vasorelaxant: NO, the first identified gasotransmitter, relaxes smooth muscle of 
various vasculatures. Substances other than NO, including low-molecular-weight S-nitrosothiol 
intermediates, also contribute to the relaxation of smooth muscle.59 60 CO is known to dilate 
different vascular tissues, from conduit arteries to resistant arteries.61 H2S-induced vasorelaxation 
has been demonstrated in numerous types of blood vessels (such as aorta, portal vein, mesenteric 
artery, cerebral arteries, and vas deferens) from different species (such as rats, mice, cows, 
guinea pigs, sheep, and humans). H2S relaxes small mesenteric arteries much more potently than 
aortic tissues.62  Although rat aortic and mesenteric artery tissues produce similar levels of H2S, 
H2S is nearly sixfold more potent in relaxing rat mesenteric artery beds than relaxing rat aortic 
tissues. The higher sensitivity of mesenteric arteries to H2S speaks for the importance of the gas 
in regulating peripheral resistance.  H2S also functions as a vasodilator in cerebral circulation. 
Topical application of H2S to the newborn pigs induces dilation of pial arterioles.63 This 
vasorelaxant effect of H2S appears to be mediated by KATP channels as glibenclamide blocks the 
H2S effect. KATP channel is the major molecular target of H2S for its vasorelaxant effect and 
smooth muscle hyperpolarization.64  
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The vasorelaxant property of this gasotransmitter gives it a role in regulating peripheral 
resistance and blood pressure. Reduced endogenous H2S level, especially in blood vessel wall, 
would be the cause for development of hypertension. Direct evidence for the role of endogenous 
H2S in blood pressure control was demonstrated in CSE knockout mice.65 The knockout mice 
manifested age-dependent development of hypertension which was comparable to that of eNOS 
KO mice.66 On the other hand, endothelium-dependent vasorelaxation, triggered by the 
activation of muscarinic cholinergic receptors on the endothelium, was severely abolished in 
CSE KO mice. Therefore, it can be concluded that hypertension in CSE KO mice is caused by 
the elimination of CSE expression in vascular tissues, especially in the endothelium.  
 
H2S as a neuromodulator.  In mammalian central nervous system (CNS), CBS was 
found highly expressed in the hippocampus and the cerebellum.67 CBS is mainly localized to 
astrocytes68 69and microglial cells, confirmed by immunohistological studies.70 The activation of 
Ca2+/calmodulin pathway after neuronal excitation activates CBS-based production of H2S. H2S 
has multifaceted and important effects in CNS, and can modulate neurotransmission and 
neuromodulation. Glutamate is an important excitatory amino acid that functions as a 
neurotransmitter. Glutamate in mammalian brain is known for its role in learning and memory, 
such as induction of long-term potentiation (LTP) and perception of pain. LTP is a memory 
consolidation process, which is ignited by a brief period of high-frequency presynaptic 
stimulation (5–100 Hz), and this initial stimulation would enhance the postsynaptic response to 
subsequent presynaptic stimulation for many hours/days after the high-frequency tetanus. 
Abnormal glutamate metabolism can lead to excitatory neuronal injury. The neurological effects 
of glutamate are mediated by N-methyl-D-aspartate (NMDA) receptors71 in both central and 
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peripheral nervous systems, with exceptions in the bone and pancreatic islet.71 It has been found 
that at physiologically relevant concentrations H2S selectively enhances NMDA receptor-
mediated currents and expedites the induction of hippocampal LTP in rats.72 On the contrary, 
high concentration of H2S would damage brain and lead to decreased learning and memory 
function. In addition to activating NMDA receptors, H2S also directly increases glutamate 
secretion. With high levels of NaHS stimulation, extracellular concentrations of glutamate were 
increased from physiological concentrations of 2–5 to 10–15 mM resulting in cell death.67 H2S-
induced cell neuron death was abolished by NMDA blocker MK-801 and glutamate antagonist 
DL-2- amino-5-phosphonovaleric acid.  
Suppression of oxidative stress is another effect of H2S in the brain. H2S inhibits protein 
oxidation, HOCl-induced cytotoxicity, intracellular protein oxidation, and lipid peroxidation. It 
also protects brain endothelial cells from methionine-induced oxidative stress.73  
 
H2S and Inflammation. H2S is known to exert both pro-inflammatory74 75 76 77 and anti-
inflammatory effects.78 79 80 81 82 The upregulation of CSE and the consequent increase in H2S 
production induced by LPS or pro-inflammatory cytokines can be viewed as a pro-inflammatory 
action83 or as an anti-inflammatory reaction as a compensatory protection mechanism. H2S 
possess an anti-proliferative effect on T-Lymphocytes and induces apoptotic death of 
polymorphonuclear cells.84 These effects limit the development of inflammation. Injection of rats 
with H2S donors, NaHS and Na2S, inhibited leukocyte infiltration and adherence to vascular 
endothelium, and edema formation in a hindpaw edema model.85 Vice versa, inhibitors of H2S 
synthesis increased leukocyte adhesion, leukocyte infiltration, and edema formation.86 
Neuroinflammation is another prominent case in point for elucidating the role of H2S in 
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inflammatory process. The activation of glial cells and release of inflammatory factors within 
brain, together with the recruitment of peripheral immune cells, jointly result in 
neuroinflammatory damage. This damage will deteriorate or lead to neurodegenerative diseases, 
such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).87 NaHS attenuates LPS-induced 
production and release of NO and TNF-a. The anti-inflammatory effect of H2S is also 
remarkable in its ability to upregulate anti-inflammatory and cytoprotective genes, such as heme 
oxygenase (HO). H2S-induced upregulation of HO expression in pulmonary smooth muscle 
cells88 and macrophages89  has been demonstrated, which is believed to be the consequence of 
ERK activation.90  
  Significant experimental evidence shows that H2S acts as a pro-inflammatory factor in 
various animal models, including hindpaw edema,91 acute pancreatitis,92 LPS-induced 
endotoxemia,93 and cecal ligation and puncture induced sepsis. Studies have shown that 
excessive activation of KATP channels occurs in LPS-induced hypotension and hyporeactivity to 
vasoconstrictor agents.94 As H2S is an identified endogenous opener of KATP channels, it was 
speculated that abnormal synthesis or activity of H2S may play a part in septic or endotoxic 
shock. It was seen that tissue H2S formation and plasma H2S concentrations were increased in a 
septic shock rat model induced by cecal ligation and puncture.95 NaHS treatment of these 
animals significantly aggravated septic inflammatory damages.96 H2S has also been reported to 
stimulate the generation of pro-inflammatory cytokines from human monocytes.97  
           One such mechanism is that H2S stimulates sensory nerve endings, releasing endogenous 
tachykinins such as substance P (SP), calcitonin gene-related peptide (CGRP), and neurokinin A, 
which causes neurogenic inflammation. A number of factors are involved in determining 
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whether H2S is anti-inflammatory or pro-inflammatory. The concentrations and administration 
routes for H2S may yield different inflammatory outcomes. 
 
A4.  Molecular mechanisms of action of Hydrogen Sulphide  
KATP channels. The activation of KATP channels by H2S is among the first identified 
molecular mechanisms for H2S. Recently discovered signaling mechanisms for H2S involves 
covalent modification of cysteine residues in proteins through S sulfhydration, converting 
cysteine -SH groups to hydropersulfide (-SSH groups).98 S sulfhydration can be explained in a 
comparative fashion with S-nitrosylation. S nitrosylation occurs between NO molecules and 
cysteine residues of the concerned proteins.99 Striking similarities between S-sulfhydration and 
S-nitrosylation are seen as both involve the covalent modification of cysteines and both are 
reversible by reducing agents, such as dithiothreitol (DTT).100 The functional outcome of the 
protein modification is different. S Sulfhydration usually contributes to the increased activity of 
the modified proteins, but S nitrosylation appears to decrease the activity it in most cases. The 
latter could be due to the shielding of critical reactive thiol groups of the proteins.  Extensive 
experiments on vascular tissues strongly suggest that H2S-induced vasorelaxation is mainly 
caused by KATP channel openings causing hyperpolarization. This notion is largely based on the 
ability of glibenclamide, a KATP channel antagonist, to block the vasorelaxant effects of H2S.101 
Electrophysiological study provides direct evidence that exogenous H2S increases macroscopic 
or unitary KATP currents, which is blocked by glibenclamide in isolated rat aortic and mesenteric 
SMCs.102 Thus, H2S-induced hyperpolarization of SMC membrane is abolished by 
glibenclamide. 
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H2S as a Reducing agent.  H2S is a strong reducing agent and may easily interact with 
other oxidative species. Its group allows the reduction of disulfide bonds and scavenging of 
reactive oxygen species and nitrogen species.103 Direct scavenge of peroxynitrite and the 
reduction of its toxicity by H2S has been reported.104 This effect would endow H2S an 
antioxidant role to offer cytoprotection.105  
 
A5.  Hydrogen Sulphide in the gastrointestinal system 
Endogenous H2S level in GI system is made up of two components. The first source is 
sulfate-reducing bacteria present in the lumen of the large intestine. The second source is from 
mammalian cells in the GI tract. H2S is produced at 0.2–3.4 mM in the GI tract of mice and 
humans by the intestinal microbiota, such as the enterobacterial flora, which use endogenous 
sulfur-containing compounds including amino acids. Both CSE and CBS are found to be 
expressed in the GI tract of rats, mice and in healthy human colon.106 107 108 In rat ileum, CBS 
and CSE mRNA were detected.109 The gastric mucosa expresses both CSE and CBS, although 
CSE appears to play a major role in H2S generation as PPG inhibits gastric H2S formation.110  
The rate of H2S production in rat ileum is comparable with that of rat aortas.111 Lysine acetyl 
salicylate injection into mice (intraperitoneally) increases the endogenous production of H2S in 
intestine.112 H2S also participates in the regulation of various GI functions, from motility control 
to secretion and inflammation. Similar to its effect on vascular contractility, H2S inhibits the 
motility of jejunum and colon in humans, mice, and rats. The precontracted ileum muscles from 
rats and guinea pigs are relaxed by NaHS in vitro.113 The spontaneous contraction of the isolated 
ileum tissues from rabbits was also inhibited by NaHS. The relaxant effect of NaHS on the 
spontaneous contraction of gastric smooth muscle appears to be mediated by the activation of 
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KATP channels. The opening of KATP channels and closing of Kv channels by NaHS had also 
been directly demonstrated on freshly dispersed gastric antrum myocytes using the whole cell 
patch-clamp recording.114 These observations suggest that two different types of ion channels are 
responsible for the dual actions of H2S on gastric motility in  guinea pigs. Another ion channel 
involved in the effect of NaHS on mouse colon is SKCa channels, since apamin at 3 mM 
inhibited NaHS-induced inhibition of colon motility.118 It is also known that H2S may also 
indirectly affect GI smooth muscle contractility by acting on neurons of the enteric nervous 
system. The presence of H2S in the mucosa/submucosa of the colon stimulates primary afferent 
nerve fibers, thus increasing chloride secretion in guinea pigs and humans.115  
 
A6. Gastric motility 
Contractions of gastric smooth muscle serves two basic functions: ingested food is 
crushed, ground and mixed, liquefying it to form what is called chyme. Chyme is forced through 
the pyloric canal into the small intestine, a process called gastric emptying. The stomach can be 
divided into two regions on the basis of motility pattern: an accordian-like reservoir that applies 
constant pressure on the lumen and a highly contractile grinder.  
The upper stomach, composed of the fundus and upper body, shows low frequency, 
sustained contractions that are responsible for generating a basal pressure within the stomach. 
Importantly, these tonic contractions also generate a pressure gradient from the stomach to small 
intestine and are thus responsible for gastric emptying. Interestingly, swallowing of food and 
consequent gastric distention inhibits contraction of this region of the stomach, allowing it to 
balloon out and form a large reservoir without a significant increase in pressure. 
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The lower stomach, composed of the lower body and antrum, develops strong peristaltic 
waves of contraction that increase in amplitude as they propagate toward the pylorus. These 
powerful contractions constitute a very effective gastric grinder; they occur about 3 times per 
minute in humans and 5 to 6 times per minute in dogs. Gastric distention strongly stimulates this 
type of contraction, accelerating liquefaction and hence, gastric emptying. The pylorus is 
functionally part of this region of the stomach - when the peristaltic contraction reaches the 
pylorus, its lumen is effectively obliterated - chyme is thus delivered to the small intestine in 
spurts.  
Gastric motility is controlled by a very complex set of neural and hormonal signals. 
Smooth muscle cells lack the striated banding pattern found in cardiac and skeletal muscle, and 
they receive neural innervation from the autonomic nervous system. In addition, the contractile 
state of smooth muscle is controlled by hormones, autocrine/paracrine agents, and other local 
chemical signals. Smooth muscle cells also develop tonic and phasic contractions in response to 
changes in load or length. Regardless of the stimulus, smooth muscle cells use cross-bridge 
cycling between actin and myosin to develop force, and calcium ions (Ca2+) serve to initiate 
contraction.116  Contraction of smooth muscle is initiated by a Ca2+-mediated change in the thick 
filaments, whereas in striated muscle Ca2+ mediates contraction by changes in the thin filaments. 
In response to specific stimuli in smooth muscle, the intracellular concentration of Ca2+ increases 
and combines with the acidic protein calmodulin. This complex activates MLC kinase to 
phosphorylate the light chain of myosin. Cytosolic Ca2+ is increased through Ca2+ release from 
intracellular stores (sarcoplasmic reticulum) as well as entry from the extracellular space through 
Ca2+ channels (receptor-operated Ca2+ channels).  
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In gastrointestinal smooth muscle cells phosphorylation of Ser19 on the 20-kDa regulatory 
light chain of myosin II (MLC20) by Ca2+/calmodulin-dependent myosin light-chain (MLC) 
kinase is essential for initiation of muscle contraction.117 118 Excitatory neurotransmitters such as 
acetylcholine initiate contraction by increasing cytosolic Ca2+, or [Ca2+]i and activation of 
Ca2+/calmodulin-dependent MLCK.119 The initial increase in [Ca2+]i and MLCK activity are 
transient.  MLC20 phosphorylation and contraction, however, are sustained via inhibition of MLC 
phosphatase.120 Inhibition of MLCP is initiated by two RhoA-dependent pathways: one involves 
phosphorylation of MYPT1, the regulatory subunit of MLC phosphatase, at Thr696 by Rho 
kinase, and the other involves phosphorylation of the endogenous MLC phosphatase inhibitor, 
CPI-17, at Thr38 by PKC.121 122 
Inhibitory neurotransmitters such as vasoactive intestinal peptide (VIP) and nitric oxide 
(NO) induce relaxation through the generation of cAMP and cGMP and activation of cAMP-
dependent protein kinase (PKA) or cGMP-dependent protein kinase (PKG).123 124 Inactivation of 
specific targets in the signaling pathways mediating contraction upon phosphorylation by cAMP-
dependent protein kinase (PKA) or cGMP-dependent protein kinase (PKG) results in muscle 
relaxation.125 PKA and PKG act on various loci to inhibit i) MLC kinase by inhibiting IP3 
generation and IP3-dependent Ca2+ release, and/or stimulating Ca2+ uptake into the sarcoplasmic 
stores, and ii) activate MLC phosphatase by phosphorylating RhoA at Ser188 and inhibiting its 
ability to activate Rho kinase, phosphorylating MYPT1 at Ser695 and blocking phosphorylation at 
the adjacent Thr696 by Rho kinase, and/or phosphorylating telokin (at Ser13), an endogenous 
MLC phosphatase stimulator.126 
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Recent studies have demonstrated that hydrogen sulphide (H2S), a gaseous transmitter 
like NO and carbon monoxide (CO) is involved in the regulation of several physiological 
functions including gastrointestinal motility.127  H2S, in addition to generation by luminal sulfate-
reducing commensal bacteria in the colon, is synthesized endogenously from L-cysteine via 
pyridoxal-5’-phosphate-dependent enzymes, cystathionine-γ-lyase (CSE) and cystathionine-β-
synthase (CBS). 3-mercaptopyruvate sulfurtransferase in combination with cysteine 
aminotransferase can also synthesize H2S from L-cysteine.128  In the gastrointestinal tract, H2S -
synthesizing enzymes have been shown to be expressed by enteric neurons, interstitial cells of 
Cajal and epithelial cells.129 Expression of CBS and CSE is tissue specific.  Reduction in the 
levels of H2S accompanied by hypertension and reduced endothelium-dependent relaxation of 
vascular muscle in mouse lacking CSE and downregulation of CSE/L-cysteine pathway in 
spontaneously hypertensive rats underscores the importance of endogenous H2S in the regulation 
of cardiovascular functions. H2S exerts its function by acting on various targets, but unlike NO 
and CO, it does not affect soluble guanylyl cyclase (sGC activity) and cGMP formation.130  
Some of the targets include activation of KATP channels, mitogen-activated protein kinase 
pathway, capsaicin-sensitive sensory neurons, T-type Ca2+ channels or interaction with NO 
synthase system.131  
One of the most studied mechanisms for muscle relaxation by H2S is activation of KATP 
channels. H2S increased KATP channels currents in smooth muscle cells of rat aorta and 
mesenteric artery. Although, it is well-established that H2S inhibits gastrointestinal motility in 
vivo and both agonist- and electrically-induced contractions in vitro, it is not known for certain 
the site of H2S biosynthesis and the mechanism of action. In guinea pig ileum and mouse 
stomach and colon, the inhibitory effect of H2S was not affected by the KATP channel inhibitor 
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glibenclamide,132 whereas in the isolated segments of human, mouse and rat colon the inhibitory 
effect of H2S was dependent on both glibenclamide-sensitive and apamin-sensitive K+ 
channels.133  The aim of the present study is to determine the effects of endogenous released and 
exogenously applied H2S on smooth muscle function and to identify the targets involved in 
mediating the effects of H2S using muscle strips and isolated muscle cells from stomach and 
colon of rabbit and mouse.  The results demonstrate that both endogenous and exogenous H2S 
induce muscle relaxation, and the mechanism involves inhibition of Rho kinase activity and 
stimulation of MLCP activity leading to MLC20 dephosphorylation. 
RATIONALE 
The role of H2S in the regulation of gastrointestinal motility in vivo and in innervated 
muscle in vitro has been demonstrated.  A direct effect of H2S on smooth muscle and the 
mechanism of action were never reported.  Hence, the aim of the present study was to examine 
the expression of H2S synthesizing enzymes in smooth muscle and characterize the mechanism of 
action of H2S involved in the regulation of smooth muscle function.  We have tested the 
hypothesis that H2S synthesizing enzyme(s) are present on smooth muscle and their activation 
results in the inhibition of muscle contraction.  A greater understanding of the H2S role in 
smooth muscle could lead to advances with important therapeutic potential in the treatment of 
gastrointestinal motility disorders.   
 
B. MATERIALS AND METHODS 
B1. Reagents  
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Antibodies for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE) were 
obtained from proteintech (Chicago, IL).  [32P]ATP was obtained from NEN Life Sciences 
Products (Boston, MA).  [125I]cAMP was obtained from PerkinElmer  Life Sciences (Boston, 
MA); Y27632 (Rho kinase inhibitor); RNAqueousTM kit was obtained from Ambion, Austin, 
TX; LipofectamineTM 2000 transfection  reagent, SuperScriptTM II Reverse Transcriptase kit 
were obtained from Invitrogen, Carlsbad, CA; PCR reagents were obtained from Applied 
Biosystems, Roche. CSE SiRNA and Negative siRNA were obtained from Ambion Life 
Technologies, Austin, TX. Collagenase CLS type II and soybean trypsin inhibitor for cell 
isolation were obtained from Worthington,  Freehold, NJ; Western blotting materials and protein 
assay kit, Tris-HCl ready gels were obtained from Bio-Rad Laboratories, Hercules, CA; 
Dulbecco’s modified eagle’s medium (DMEM) for primary cell culture was obtained from 
Fisher Scientific. All other chemicals were obtained from Sigma, St. Louis, MO. 
B2. Animals 
New Zealand white rabbits (weight: 4-5 lbs) were purchased from RSI Biotechnology, 
Clemmons, NC and euthanized by sodium pentobarbital overdose (100 mg/kg), as approved by 
the Institutional Animal Care and Use Committee of the Virginia Commonwealth University. 
The animals were housed in the animal facility administered by the Division of Animal 
Resources, Virginia Commonwealth University.  All procedures were conducted in accordance 
with the Institutional Animal Care and Use Committee of the Virginia Commonwealth 
University.   
B3.  Preparation of dispersed smooth muscle cells.   
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Smooth muscle cells were isolated from the circular muscle layer of rabbit proximal 
stomach (fundus) by sequential enzymatic digestion, filtration, and centrifugation, as previously 
described.134 135 136 Briefly, smooth muscle strips were incubated for 30 min at 31oC in 15 ml of 
medium containing 120 mM NaCl, 4 mM KCl, 2.6 mM KH2PO4, 0.6 mM MgCl2, 25 mM 
HEPES, 14 mM glucose, 2.1% (v/v)  Eagle’s essential amino acid mixture, 0.1% collagenase 
(type II), and 0.1% soybean trypsin inhibitor. Partly digested tissues were washed with 50 ml of 
enzyme-free medium and muscle cells allowed to disperse spontaneously. The cells were 
harvested by filtration through 500mm Nitex and centrifuged twice at 350g for 10 min to 
eliminate cells and organelles. The experiments were done within 2-3 hours of isolation.   
B4- Preparation of cultured gastric smooth muscle cells  
           Dispersed muscle cells isolated from the stomach were resuspended in DMEM containing 
penicillin (200 U/ml), streptomycin (200 µg/ml), gentamycin (100 µg/ml),  amphotericin B (2.5 
µg/ml) and 10% fetal bovine serum (DMEM-10). The muscle cells were plated at a 
concentration of 5 X 105 cells/ml and incubated at 37°C in a 10% CO2 incubator. DMEM-10 
medium was replaced every three days for 2-3 weeks until confluence was attained. The muscle 
cells in confluent primary cultures were trypsinized (0.5 mg trypsin/ml), re-plated at a 
concentration of 2.5 X 105 cells/ml and cultured under the same conditions. All experiments 
were done on cells in the first passage.     
B5.  RT-PCR analysis of CBS and CSE. 
Specific primers were designed based on homologous sequences in human, rat, and 
mouse CBS and CSE. The primers for Rabbit CSE were Forward 5’-ACA TTT CGC CAC GCA 
GGC CA-3’ and, Reverse 5’-CTC CCA GAG CCA AAG GCC GC-3’, generating a fragment of 
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560 bp. The primers for  mouse CSE were Forward 5’- GGG CAT CTG CAG GGA AAG GAA 
CG-3’ and Reverse 5’-GCA GAT TGG TCC ACG CCC CT-3’, generating a fragment of 851 bp. 
The primers for human CSE were Forward 5’-TGG ATG GGG CTA AGT ACT GTT TGG C-3’ 
and Reverse 5’-CAG AGC CAA AGG GCG CTG GAA A-3’, generating a fragment of 312 bp. 
Cultured gastric muscle cells were treated with RNaqueous reagent (Ambion, Austin, TX) 
followed by an extraction with phenol:chloroform:isoamylalcohol (25:24:1). RNA (5 ml) was 
used to synthesize cDNA using Superscript II reverse transcriptase (Applied Biosystems, Foster, 
CA) with random hexanucleotide primers.  Reversibly transcribed cDNA (5 ml) was amplified by 
PCR under standard conditions using the HotMaster Taq DNA polymerase kit (Epicentere 
Biotechnologies, Madison, WI) in a final volume of 50 ml containing 100 ng of each primer. The 
PCR products were separated by electrophoresis in 1.2% agarose gel in the presence of ethidium 
bromide, visualized by ultraviolet fluorescence, and recorded by a ChemiImager 4400 
Fluorescence system.  
B6. Western blot analysis for CBS and CSE.   
Freshly dispersed or cultured smooth muscle cells were solubilized in Triton X-100-
based lysis buffer plus protease and phosphatase inhibitors. After centrifugation of the lysates at 
20,000 g for 10 min at 4°C, protein concentrations of the supernatant were determined with the 
DC Protein Assay kit from Bio-Rad (Hercules, CA). Proteins (50 µg) were separated by SDS-
PAGE and transferred to nitrocellulose membranes (Immobilon-FL, Millipore, Billerica, MA). 
The blots were incubated for 12 h at 4°C with antibodies (1:1,000) to CBS and CSE and then for 
1 h with secondary antibody conjugated with horseradish peroxidase. The protein bands were 
visualized by enhanced chemi-luminescence. 
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B7. Transfection of CSE siRNA in cultured gastric cells 
CSE-targeted 21 nucleotide siRNA duplex was purchased from Ambion (Austin, TX, 
USA). Negative control siRNA, a 21 nucleotide RNA duplex with no sequence homology with 
all known genes, was also purchased from Ambion. Transfection of siRNA into cultured smooth 
muscle cells from rabbit gastric was achieved using the lipofectamine 2000 transfection reagent 
from Invitrogen. Briefly, cells were plated overnight to form 80-90% confluent monolayers. CSE 
siRNA at 40 nM and the transfection reagent complex were added to cells in serum-free medium 
for 24 h. As a control, negative siRNA was used to transfect rabbit gastric cells. 
B8. Measurement of adenylyl cyclase activity 
Adenylyl cyclase activity was measured by the formation of the second messenger cAMP 
in response to the exogenous donor of H2S, NaHS and the endogenous activator of H2S, L-
Cysteine. Radioimmunoassay using radiolabeled [125I] cAMP was performed to measure the 
level of cAMP production. Forsoklin, which is an activator of adenylyl cyclase (AC) is used as a 
positive control. The levels of cAMP in response to the NaHS and L-Cysteine are compared to 
the cAMP levels induced by forsoklin. One milliliter of cell suspension contains approximately 3 
x 106 cells/ml. The experiments were performed after the cells were treated with NaHS (1mM) 
and L-Cysteine (10mM). Another set of cells were treated with 10µM of forskolin. Following 
treatment the reaction was terminated with cold 6% trichloroacetic acid (v/v) and vortexed 
vigorously. The mixture was then centrifuged and the supernatant was collected and were 
extracted three times with water-saturated diethyl ether to remove the trichloroacetic acid and 
then lyophilized and frozen at -20oC. Before radioimmunoassay, the samples were reconstituted 
in 500 µl of 50mM sodium acetate (pH 6.2) and acetylated with triethylamine/acetic anhydride 
(2:1 v/v) for 30 min. Cyclic AMP was measured in triplicates using 100 µl aliquots and the 
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results were analyzed and derived from a standard curve using Prism @ GraphPad program. The 
results were expressed as pmol of cAMP/mg protein 
B9. Assay for Rho kinase activity. 
 Rho kinase activity was determined in cell extracts by immunokinase assay as previously 
described.137 Freshly dispersed smooth muscle cells from rabbit stomach were treated the 
contractile agonist carbachol (0.1 µM) in the presence or absence of different concentrations of 
NaHS or L-Cysteine for 10 min and solubilized in lysis buffer containing 50 mM Tris-HCl (pH 
7.5), 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40, 150 mM NaCl, 1 mM PMSF, 10 
mg /ml aprotinin, 10 mg /ml pepstatin A, and 10 mg /ml leupeptin.  Equal amounts of protein 
extracts were incubated with Rho kinase-2 antibody plus protein A/G agarose overnight at 4°C. 
Immunoprecipitates were washed twice with a phosphorylation buffer containing 10 mM MgCl2 
and 40 mM HEPES (pH 7.4) and then incubated for 5 min on ice with myelin basic protein 
(MBP) (1 mg/ml) as a substrate for Rho kinase activity. The kinase reaction was initiated by the 
addition of 10 mCi of [32P]ATP (3,000 Ci/mmol) and 20 mM ATP, followed by an incubation for 
10 min at 37°C. 32P-labeled myelin basic protein was absorbed onto phosphocellulose disks, and 
repeated washings with 75 mM phosphoric acid removed unbound [32P]ATP. The extent of 
phosphorylation was determined from the radioactivity on phosphocellulose discs by liquid 
scintillation. 
B10. Measurement of contraction and relaxation in muscle strips.  
  Circular muscle Strips from the proximal stomach of rabbit were collected and rinsed 
immediately in Kreb’s solution containing 118 mM NaCl, 4.8 mM KCl, 1mM MgSO4, 1.15 mM 
NaH2PO4, 15 mM NaHCO3, 10.5 mM Glucose and 2.5 mM CaCl2.  Muscle strips were cut along 
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the circular axis and tied at each end with silk thread and mounted vertically in 5 ml tissue bath 
containing oxygenated (95% O2/5%CO2) Kreb’s solution at a pH of 7.4 at 37ºC. The tissues were 
mounted between glass rod and an isometric transducers (Grass Technologies) connected to a 
computer recording system (Polyview). Preparations were allowed to equilibrate for 1 h at 
resting tension (2g) before initiation of experiments and bath buffer solution was changed every 
15 minutes during equilibration. To measure NaHS or L-cysteine induced relaxation, the strips 
were precontracted with 10 mM CCh, and after obtaining stable sustained contraction different 
concentrations of L-cysteine or NaHS were cumulatively added. In a separate study 10 mM 
glibenclamide, a KATP channel blocker was added to the organ bath for 15 min before CCh or 
NaHS or L-cysteine treatment.  At the end of each experiment, the strips were blotted dry and 
weighed (tissue wet weight).  Contractile activity of muscle strips from stomach was calculated 
as maximum force generated in response to CCh and relaxation was calculated as percent 
decrease in maximum contraction 
B11.  Measurement of contraction and relaxation in freshly isolated muscle cells. 
Contraction in freshly dispersed gastric smooth muscle cells was determined by scanning 
micrometry as previously described (22-24).  Freshly isolated muscle cells (0.4 ml) containing 
(104/cell ml) from proximal stomach were preincubated with different concentrations of L-
cysteine, NaHS and then 10mM CCh was added for 10 min.  The reaction was terminated with 
1% acrolein. The same experiments were repeated in cells preincubated for 15 min with a KATP 
channel inhibitor 10 mM glibenclamide. The resting cell length was determined in control 
experiments in which muscle cells were incubated with 100 ml of 0.1% bovine serum albumin in 
the absence of CCh. The mean cell length of 50 muscle cells was measured by scanning 
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micrometry.  Contraction in response to CCh was expressed as decrease in mean cell length from 
control cell length and relaxation was measured as percent decrease in contractile response in the 
presence of L-cysteine and NaHS.   
B12.  Statistical Analysis 
The results were expressed as means +S.E.M of n experiments and analyzed for statistical 
significance using Student t-test for paired and unpaired values. Each experiment was performed 
on cells and tissues obtained from different animals. Difference of responses among different 
groups were tested and confirmed for significance using Fisher’s protected least significance 
difference test. The results were analysed using GraphPad software, San Diego, CA. A 
probability of P< 0.05 was considered significance.   
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 RESULTS 
C1.  Expression of CSE enzyme in smooth muscle cells from stomach and colon.   
To examine the role of endogenous H2S in the regulation of muscle function, expression 
of the two main enzymes involved in the synthesis of H2S was determined by RT-PCR and 
western blot.  mRNA expression was determined in cultured muscle cells to avoid amplification 
from cell other than muscle cells.  Previous studies have determined the purity of cultured 
muscle cells with smooth muscle-specific g-actin and absence of interstitial cells of Cajal and 
endothelial cells in the primary cultures after first passage138  Expression of mRNA for CSE, but 
not CBS was detected in muscle cells from stomach and colon.  A PCR product of the expected 
size was obtained with CSE specific primers using RNA isolated from cultured muscle cells 
derived from the stomach and colon of rabbit (560 bp), mouse (851 bp) and human (312 bp)  
(Fig. 1A).  Under similar conditions, there was no detectable PCR product with CBS-specific 
primers using RNA from cultured muscle cells of the stomach and colon of rabbit, mouse and 
human.  However, a PCR product of expected size was obtained using CBS-specific primers 
with RNA isolated from mouse STC-1 cells (data not shown).   
Western blot analysis using specific antibody to CSE demonstrated the presence of CSE 
protein (66 kDa) in lysates derived from muscle cells of the stomach and colon (Fig. 1B).  Under 
similar conditions, there was no detectable expression of CBS protein with the lysates derived 
from dispersed muscle cells of the stomach and colon of rabbit, mouse and human.  However, 
expression of CBS protein was obtained using CBS-specific antibody with lysates prepared from 
mouse STC-1 cells (data not shown).  These results suggest that muscle cells selectively express 
CSE and this is consistent with the tissue-specific expression of CSE and CBS.139     
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C2.  Inhibition of contraction by H2S in muscle strips.   
We next examined the role of H2S in the regulation of muscle function by isometric 
contraction and scanning micrometry.  Isometric contraction was measured by organ bath in 
muscle strips and by scanning micrometry in freshly dispersed muscle cells. Muscle strips from 
the proximal stomach were allowed to equilibrate to a passive tension 2g for 1hr before 
experiments were conducted.  Sustained peak contraction in response to CCh was defined as tone 
above basal.   As shown previously140, carbachol (CCh, 10 µM) induced a sustained contraction 
of 12 g above basal tension.  Addition of L-cysteine caused inhibition of CCh-induced 
contraction (i.e. relaxation) in a concentration-dependent fashion (Fig. 2).  Relaxation responses 
were  5±3 % at 1 mM L-cysteine (NS), 21±3% at 10 mM L-cysteine (p<0.01), and 55±5 % at 
100 mM L-cysteine (p<0.01).  Previous studies141 in vascular and visceral muscle have shown 
that relaxation in response to H2S was mediated by activation of plasma membrane KATP 
channels and hyperpolarization.  The notion was examined using KATP channel inhibitor 
glibenclamide.  Incubation of muscle strips with glibenclamide (10μM) did not affect the 
relaxation in response to L-cysteine: 18±4% at 1 mM L-cysteine (p<0.01), 28±4% at 10 mM L-
cysteiene (p<0.01), and 68±5% at 100 mM L-cysteine (p<0.001) (Fig 2).  The results suggest 
that relaxation of sustained contraction by L-cysteine was not due to activation of KATP channels.  
Addition of H2S donor, NaHS also caused inhibition of CCh-induced contraction in a 
concentration-dependent fashion (Fig. 3).  Relaxation responses were 52±4 % at 1 mM NaHS 
(p<0.001), 97±8% at 10  mM NaHS (p<0.001), and 100±9% at 100 mM NaHS (p<0.001).  As in 
response to L-cysteine, relaxation in response to NaHS was not affected by incubation of muscle 
strips with glibenclamide (Fig. 3):  68±5% at 1 mM NaHS (p<0.001), 97±10% at 10 mM NaHS 
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(p<0.001), 96±9% at 100 mM NaHS (p<0.001) (Fig. 3).  The results suggest that relaxation of 
sustained contraction by H2S was not due to activation of KATP channels.   
C3. Inhibition of contraction by H2S in isolated muscle cells.  
Relaxation in response to L-cysteine and NaHS in innervated muscle strips could be due 
to release of transmitters from the enteric neurons, which in turn, modulate the intrinsic electrical 
and mechanical activity of the gastrointestinal smooth muscle.143 To avoid the confounding 
effects of neural activation by H2S, we examined the effect of L-cysteine and NaHS on CCh-
induced muscle contraction in freshly dispersed muscle cells by scanning micrometry.  As in 
muscle strips, contractile agonist induce biphasic contraction in isolated muscle cells: a rapid 
contraction within 30 s followed by a sustained contraction for 20 min.143 To examine the effect 
of L-cysteine or NaHS on sustained contraction, muscle cells were treated with different 
concentrations of CCh (0.1 nM to 10 μM) in the presence or absence of L-cysteine (10 mM) or 
NaHS (1 mM) for 10 min.  CCh caused a concentration-dependent contraction in dispersed 
muscle cells with an EC50 of 12 nM.  In the presence of L-cysteine or NaHS the contractile 
response to CCh was shifted to the right suggesting inhibition of contraction with EC50 values of 
25 nM and 79 nM, respectively (Fig.  4).   Addition of L-cysteine caused inhibition of CCh-
induced contraction (i.e. relaxation) in a concentration-dependent fashion (Fig. 5).   Relaxation 
responses were 35±5% at 1 mM L-cysteine (p<0.001), 58±6% at 10 mM L-cysteine (p<0.001), 
and 79±8% at 100 mM L-cysteine (p<0.001).  Addition of NaHS also caused relaxation in a 
concentration-dependent fashion (Fig.  6). Relaxation responses were 50±5 % at 1 mM NaHS   
(p<0.001), 65± 7% at 10 mM NaHS (p<0.001), and 83±6% at 100 mM NaHS (p<0.001) (Fig.  
6).  The effect of 10 mM L-cysteine (39±3% vs 36±4% relaxation ) or 1 mM NaHS (48±5% vs. 
47±6% relaxation) on CCh-induced contraction was not affected in the presence of 
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glibenclamide (Fig.  7). Control studies showed that relaxation (52±7% relaxation) in response to 
levcromakalin, a potassium channel activator was inhibited by glibenclamide (8±4% relaxation). 
(Fig 8). The results suggest that both endogenous (via activation of CSE by L-cysteine) and 
exogenous H2S inhibit muscle contraction.  The results also suggest that the inhibitory effect of 
H2S is independent of KATP channel activation. 
C4. Mechanism of action of H2S to mediate muscle relaxation 
Previous studies have shown that muscle relaxation in response to inhibitory transmitters 
such as VIP or NO was mediated by generation of cAMP and cGMP, and activation of cAMP-
dependent kinase (PKA) and cGMP-dependent protein kinase (PKG), respectively. Selective 
inhibitors of PKA (H-89) or PKG (Rp-cGMPS) were used to examine the involvement of PKA 
and PKG in L-cysteine- and NaHS-induced relaxation.  Relaxation in response to 10 mM L-
cysteine (48±5% relaxation) was not affected by 1 μM H-89 (51±6% relaxation) or 1 μM Rp-
cGMPS (42±5% relaxation) (Fig. 9).   Similarly, relaxation in response to 1 mM NaHS (59±4% 
relaxation) was not affected by 1 μM H-89 (55±5% relaxation) or 1 μM Rp-cGMPS (51±4% 
relaxation) (Fig. 9).  Control studies showed that relaxation in response to NO donor, S-
nitrosoglutathione (GSNO, 10 µM) which generates cGMP and activates PKG was inhibited by 
Rp-cGMPS, but not by H-89 (61±8% relaxation with GSNO, 12±4% relaxation with GSNO and 
Rp-cGMPS, and 52±6% relaxation with GSNO and H-89) (Fig 10). Relaxation in response to 
forskolin, which generates cAMP and activates PKA was inhibited by H-89, but not by Rp-
cGMPS (65±4% relaxation with forskolin, 12±4% relaxation with forskolin and H-89, and 
58±5% relaxation with forskolin and Rp-cGMPS) (Fig. 10).  These results suggest that relaxation 
by H2S was independent of PKA and PKG activation.     
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C4a.  Effect of H2S on cAMP levels in isolated muscle cells from the stomach 
Lack of effect of PKA inhibitor on muscle relaxation in response to L-cysteine and NaHS 
was corroborated by measurements of cAMP.  Muscle cells were treated with L-cysteine (10 
mM), NaHS (1 mM) or forskolin (10mM) for 5 min in the presence of IBMX (10 µM) and cAMP 
levels are measured by radioimmuno assay.  Treatment of cells with L-cysteine (2.1±0.35 
pmol/mg protein) or NaHS (2.6±0.4 pmol/mg protein) did not change the levels of cAMP 
compared to basal cAMP levels (1.8±0.25 pmol/mg protein) (Fig.  11). In contrast, forskolin 
caused a significant increase (17.6±2.1 pmol/mg protein, p<0.001) in cAMP levels above basal 
levels (Fig. 11).  These results suggest that H2S does not stimulate adenylyl cyclase activity and 
increase the cAMP levels in the gastric muscle cells; but induce relaxation through other 
pathways that inhibit contraction.  
C4b.  Inhibition of Rho kinase activity by H2S. 
Previous studies in gastric muscle have shown sustained contraction in response to CCh 
is mediated by activation of RhoA/Rho kinase pathways involving phosphorylation of MYPT1, 
the regulatory subunit of MLC phosphatase, via Rho kinase leading to inhibition of MLC 
phosphatase and increase in MLC20 phosphorylation, a prerequisite for contraction.  As shown 
previously, sustained contraction (31±3% decrease in cell length) in response to CCh was 
inhibited by the selective Rho kinase inhibitor, Y27632 (1 mM) (4±4% decrease in cell length) 140 
(Fig. 12).  We next examined the hypothesis that inhibition of contraction by H2S is due to 
inhibition of Rho kinase leading to activation of MLC phosphatase and MLC20 
dephosphorylation, a prerequisite for relaxation.   
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As shown previously140, treatment of cells with 0.1 μM CCh for 10 min caused a 
significant increase in Rho kinase activity above basal levels (268±12% increase, p<0.001) (Fig. 
13).  Addition of L-cysteine (10 mM) caused significant inhibition of CCh-stimulated Rho kinase 
activity (62±4% inhibition, p<0.001).  Similarly, addition of NaHS (1 mM) caused significant 
inhibiton of CCh-stimulated Rho kinase activity (76±6% inhibition, p<0.001) (Fig. 13).  These 
results suggest that relaxation of sustained contraction by H2S was due to inhibition of Rho 
kinase activity.    
C4c. Inhibition of Rho kinase activity by L-cysteine is mediated via CSE/ H2S 
The involvement of endogenous H2S generation in the inhibition of Rho kinase by L-
cysteine was examined by transfection of cultured muscle cells with CSE specific siRNA.  
Suppression of CSE was verified by western blot (Fig. 14). CCh induced significant increase 
(238±15% increase above basal level) in Rho kinase activity in cultured muscle cells.   Addition 
of L-cysteine (10 mM) caused significant inhibition of CCh-stimulated Rho kinase activity 
(85±8% inhibition) in cells transfected with control siRNA but not in cells transfected with CSE-
specific siRNA (19±9% inhibition) (Fig. 14). These results provide evidence for the involvement 
of CSE, probably via generation of H2S, in the inhibition of Rho kinase activity.  
In summary, 
1.  CSE, but not CBS is expressed in gastric smooth muscle cells.  
2.  L-cysteine, an activator of CSE, and H2S donor NaHS caused relaxation of sustained 
contraction in a concentration-dependent fashion in muscle strips.   Relaxation by L-cysteine and 
NaHS was not affected by the KATP channel blocker, glibenclamide.  
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3.  L-cysteine and NaHS caused relaxation of sustained contraction in a concentration-dependent 
fashion in freshly dispersed muscle cells.  Relaxation by L-cysteine and NaHS was not affected 
by the KATP channel blocker, glibenclamide, PKA inhibitor, H-89 or PKG inhibitor, Rp-cGMPS.  
L-cysteine and NaHS had no effect on cAMP levels.   
4.  L-cysteine and NaHS caused inhibition of CCh-stimulated Rho kinase activity. Previous 
studies have shown that sustained contraction by CCh was inhibited by the selective Rho kinase 
inhibitor, Y27632 (1 µM). 
5.  Inhibition of Rho kinase activity by L-cysteine was blocked in cells transfected with CSE 
specific siRNA.  
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Figure 1.  Expression of CSE in smooth muscle cells.  (A) CSE expression was identified in 
cultured muscle cells from stomach and colon of rabbit, mouse and human by RT-PCR.   A PCR 
product of the expected size was obtained with CSE specific primers using RNA isolated from 
cultured muscle cells derived from stomach and colon of rabbit (560 bp), mouse (851 bp) and 
human (312 bp).  Under similar conditions, there was no detectable PCR product with CBS-
specific primers from cultured muscle cells of stomach and colon of rabbit, mouse and human. 
(B) Western blot analysis using specific antibody to CSE (1:1000) demonstrated the presence of 
CSE protein (66 kDa) in lysates derived from muscle cells of stomach and colon of rabbit, mouse 
and human.  Under similar conditions, there was no detectable expression of CBS protein with 
the lysates derived from dispersed muscle cells of stomach and colon of rabbit, mouse and 
human.  
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Figure 1-A- Expression of mRNA
  
 
Figure 1-B- CSE protein expression 
 
 
43 
 
 
 
 
 
 
Figure 2. Effect of L-cysteine on carbachol-induced contraction in gastric muscle strips. 
Muscle strips from rabbit proximal stomach were allowed to equilibrate to a passive tension of 
2g for 30 min and then treated with carbachol (CCh, 10 µM).  The increase in tension (increase 
in the amplitude) in response to CCh was calculated as contraction.   After the muscle attained 
sustained contraction, different concentrations of L-cysteine was added in the presence or 
absence of glibenclamide (10 µM).  Inhibition of contraction was calculated as relaxation and 
expressed as percent inhibition of maximum tension. Values are means ± SEM of 4 experiments.  
** p<0.001 significant inhibition of CCh-induced contraction. 
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Figure 3. Effect of NaHS on carbachol-induced contraction in gastric muscle strips. Muscle 
strips from rabbit proximal stomach were allowed to equilibrate to a passive tension of 2g for 30 
min and then treated with carbachol (CCh, 10 µM).  The increase in tension (increase in the 
amplitude) in response to CCh was calculated as contraction.   After the muscle attained 
sustained contraction, different concentrations of NaHS was added in the presence or absence of 
glibenclamide (10 µM).  Inhibition of contraction was calculated as relaxation and expressed as 
percent inhibition of maximum tension. Values are means ± SEM of 4 experiments.  ** p<0.001 
significant inhibition of CCh-induced contraction. 
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Figure 4.  Effect of L-cysteine and NaHS on carbachol-induced contraction in isolated 
muscle cells of stomach.  Muscle cells isolated from proximal stomach were treated with 
different concentrations of CCh (0.1nM to 10 µM) for 10 min.  In some experiments cells were 
pretreated for 10 min with 10mM L-cysteine or 1mM NaHS and then treated with CCh.  Muscle 
cell length was measured by scanning micrometry.  Contraction by CCh was calculated as 
decrease in muscle length from control cell length of 104±5 mm.   Values are means ± SEM of 7 
experiments.  
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Figure 5.  Effect of L-cysteine on carbachol-induced contraction in isolated muscle cells of 
stomach.  Muscle cells isolated from proximal stomach were treated with CCh (0.1 µM) for 10 
min to induce sustained contraction.  In some experiments cells were pretreated with different 
concentrations of L-cysteine for 10 min and then treated with CCh for 10 min.  Muscle cell 
length was measured by scanning micrometry.  Contraction by CCh was calculated as decrease 
in muscle length from control cell length (30±3% decrease in cell length from the basal cell 
length of 109±5 mm). Relaxation by L-cysteine was expressed as percent decrease in CCh-
induced contraction.   Values are means ± SEM of 7 experiments. ** p<0.001, significant 
inhibition of CCh-induced contraction. 
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Figure 6.  Effect of NaHS on carbachol-induced contraction in isolated muscle cells of 
stomach.  Muscle cells isolated from proximal stomach were treated with CCh (0.1 µM) for 10 
min to induce sustained contraction.  In some experiments cells were pretreated with different 
concentrations of NaHS for 10 min and then treated with CCh for 10 min.  Muscle cell length 
was measured by scanning micrometry.  Contraction by CCh was calculated as decrease in 
muscle length from control cell length (30±3% decrease in cell length from the basal cell length 
of 109±5 mm). Relaxation by NaHS was expressed as percent decrease in CCh-induced 
contraction.   Values are means ± SEM of 7 experiments. ** p<0.001, significant inhibition of 
CCh-induced contraction. 
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Figure 7.  Effect of glibenclamide on relaxation induced by L-cysteine and NaHS in isolated 
muscle cells of stomach.  Muscle cells isolated from proximal stomach were treated with CCh 
(0.1 µM) for 10 min to induce sustained contraction.  In some experiments cells were pretreated 
with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of glibenclamide (10 µM) 
for 10 min and then treated with CCh for 10 min.  Muscle cell length was measured by scanning 
micrometry.  Contraction by CCh was calculated as decrease in muscle length from control cell 
length (29±4% decrease in cell length from the basal cell length 104±5 mm).  Relaxation in 
response to L-cysteine or NaHS was expressed as percent decrease in contraction.   Values are 
means ± SEM of 7 experiments. ** p< 0.01, significant inhibition of CCh-induced muscle 
contraction. 
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Figure 8.  Effect of glibenclamide on relaxation induced by levcromakalin in isolated 
muscle cells of stomach.  Muscle cells isolated from proximal stomach were treated with CCh 
(0.1 µM) for 10 min to induce sustained contraction.  In some experiments cells were pretreated 
with levcromakalin (10 µM) in the presence or absence of glibenclamide (10 µM) for 10 min and 
then treated with CCh for 10 min.  Muscle cell length was measured by scanning micrometry.  
Contraction by CCh was calculated as decrease in muscle length from control cell length (29±4% 
decrease in cell length from the basal cell length 104±5 mm).  Relaxation in response to 
levcromakalin was expressed as percent decrease in contraction.   Values are means ± SEM of 4 
experiments. ** p< 0.001, significant inhibition of CCh-induced muscle contraction. 
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Figure 9.  Effect of H-89 and Rp-cGMPS on relaxation induced by L-cysteine and NaHS in 
isolated muscle cells of stomach.  Muscle cells isolated from proximal stomach were treated 
with CCh (0.1 µM) for 10 min to induce sustained contraction.  In some experiments cells were 
pretreated with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of PKA 
inhibitor, H-89 (1 µM) or PKG inhibitor, Rp, cGMPS (1 µM) for 10 min and then treated with 
CCh for 10 min.  Muscle cell length was measured by scanning micrometry.  Contraction by 
CCh was calculated as decrease in muscle length from control cell length (29±4% decrease in 
cell length from the basal cell length 104±5 mm).  Relaxation in response to L-cysteine or NaHS 
was expressed as percent decrease in contraction.   Values are means ± SEM of 7 experiments. 
** p< 0.001, significant inhibition of CCh-induced muscle contraction. 
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Figure 10.  Effect of H-89 and Rp-cGMPS on relaxation induced by forskolin and S-
nitrosoglutathione, respectively, in isolated muscle cells of stomach.  Muscle cells isolated 
from proximal stomach were treated with CCh (0.1 µM) for 10 min to induce sustained 
contraction.  In some experiments cells were pretreated with GSNO  (10 µM) in the presence or 
absence of Rp-cGMPS (1 µM) or forskolin (10 µM) in the presence or absence of H-89 (1 µM) 
for 10 min and then treated with CCh for 10 min.  Muscle cell length was measured by scanning 
micrometry.  Contraction by CCh was calculated as decrease in muscle length from control cell 
length (29±4% decrease in cell length from the basal cell length 104±5 mm).  Relaxation in 
response to GSNO or forskolin was expressed as percent decrease in contraction.   Values are 
means ± SEM of 4 experiments. ** p< 0.001, significant inhibition of CCh-induced muscle 
contraction. 
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Figure 11: Effect of L-cysteine and NaHS on adenylyl cyclase activity in isolated muscle 
cells of stomach.  Muscle cells isolated from proximal stomach were treated with NaHS (1 mM) 
and L-Cysteine (10 mM), or forskolin (10 µM) for 5 min.  Stimulation of adenylyl cyclase 
activity was measured as increase in cAMP levels above basal levels cAMP levels were 
measures by radioimmunoassay. Results are expressed as pmol/mg protein. ** p<0.001 
significant increase in cAMP levels. 
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Figure 12.  Effect of Rho kinase inhibitor in CCh-induced sustained contraction.  Muscle 
cells isolated from proximal stomach were treated with CCh (0.1 µM) in the presence or absence 
of the Rho kinase inhibitor Y27632 (1 µM) for 10 min to induce sustained contraction.  Muscle 
cell length was measured by scanning micrometry.  Contraction by CCh was calculated as 
decrease in muscle length from control cell length (31±3% decrease in cell length from the basal 
cell length 101±6 mm).  Values are means ± SEM of 4 experiments. ** p< 0.01, significant 
inhibition of CCh-induced muscle contraction. 
 
 
 
 
 
 
 
 
 
 
64 
 
Figure 12 
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
 
 
 
 
 
 
Figure 13.  Effect of L-cysteine and NaHS on carbachol-stimulated Rho kinase activity in 
isolated muscle cells of stomach.  Muscle cells isolated from proximal stomach were treated 
with CCh for 10 min.  In some experiments cells were pretreated with L-cysteine (10 mM) or 
NaHS (1 mM) for 10 min and then treated with CCh for 10 min.  Rho kinase activity was 
measured by immunokinase assay using [32P]ATP.  Results are expressed as cpm/mg protein. 
Values are means ±SEM of 4-6 experiments. **p<0.001 significant inhibition of CCh-stimulated 
Rho kinase activity.  
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Figure 14.  Effect of CSE siRNA on L-cysteine-induced inhibition of Rho kinase activity.   
Cultured gastric muscle cells were transfected with control siRNA or CSE-specific siRNA for 48 
h.  Expression of CSE was measured by western blot (inset).  Cells were treated with CCh (0.1 
µM) for 10 min   In some experiments the transfected cells were pretreated for 10 min with L-
cysteine (10 mM) and then treated with CCh for 10 min.  Rho kinase activity was measured by 
immunokinase assay using [32P]ATP.  Results are expressed as cpm/mg protein. Values are 
means±SEM of 4-6 experiments.  **p< 0.001, significant inhibition of CCh-stimulated Rho 
kinase activity by L-cysteine. 
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D. DISCUSSION 
Though the existence of H2S in biological tissues has been known for over 300 years, it is 
the most recently appreciated of the gasotransmitters as a physiologic messenger molecule. 
Regarded as a third gasotransmitter, H2S is receiving increasing interest, as much as NO and CO 
has received previously, to understand its physiological functions.142 Using exogenous H2S 
donors or activators of endogenous enzymes such as CSE and CBS that generate H2S, CSE 
siRNA and CSE-/- mice, regulation of several functions by H2S has been demonstrated and these 
include cardiovascular, gastrointestinal and central nervous system, and energy metabolism. 
Inhibitors of these enzymes have been employed to characterize influences of H2S in various 
organs in mammals. Definitive evidence that H2S is a physiologic regulator came with the 
knockout mice with targeted deletion of CSE and CBS.  
In the gastrointestinal (GI) tract, H2S synthesizing enzymes are expressed by enteric 
neurons, interstitial cells of Cajal and in the epithelium.143 In addition, the gut microbiota 
produces H2S which leads to luminal concentrations of H2S of up to 1 mM.144  Transcripts 
encoding both CSE and CBS have been identified in different cell types in the GI system. H2S is 
produced by activation of these enzymes but no evidence indicates the physiological mechanisms 
of activation of the H2S synthesizing enzymes. Recently, several studies reported actions of H2S 
on various GI functions. These functions include inflammatory and anti-inflammatory, 
nociceptive and anti-nociceptive actions, and regulation of gastric mucosal blood flow, secretion 
and GI motility.145 146  Currently, the most advanced efforts to develop therapeutic agents involve 
the combination of H2S donors with non-steroidal anti-inflammatory drugs (NSAIDs). The H2S 
releasing moiety provides cytoprotection to gastric mucosa normally adversely affected by 
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NSAIDs while the combination of H2S and inhibition of prostaglandin synthesis may afford 
synergistic anti-inflammatory influences.  
The important findings of our study are summarized as follows: i) transcripts of the H2S-
synthesizing enzymes CSE, but not CBS have been detected in isolated muscle cells,  where it is 
responsible for H2S production; ii) endogenous activation of CSE by L-cysteine inhibited 
agonist-induced Rho kinase activity and muscle contraction; iii) suppression of CSE expression 
blocked the effect of L-cysteine on Rho kinase activity providing strong evidence that H2S may 
be responsible for L-cysteine-induced inhibitory effects;  iv) exogenous H2S donor, NaHS 
inhibited agonist-induced Rho kinase activity and muscle contraction, v)  the effect of L-cysteine 
and NaHS was not affected by blockade of KATP channel with glibenclamide, PKA with H-89 or 
PKG with Rp-cGMP.  These studies suggest that a distinct PKA/PKG-independent mechanism 
via inhibition of Rho kinase activity mediates muscle relaxation by H2S.   
Recent studies in vascular and visceral smooth muscle have clearly established the H2S as 
a mediator of relaxation.   Expression of CSE is down regulated in hypertensive animal models.  
CSE-/- mice are hypertensive and exhibit reduced endothelium-dependent vasorelaxation; these 
effects are associated with decrease in H2S generation in these mice.   Exogenous H2S 
administration reduced blood pressure, whereas inhibition of CSE activity with DL-
propargylglycine increased blood pressure in rats.147 Extensive experiments on vascular tissues 
strongly suggest that H2S-induced vasorelaxation is mainly caused by KATP channel openings. 
This notion is largely based on the ability of glibenclamide, a KATP channel antagonist, to block 
the vasorelaxant effects of H2S.148  Systemic administration of different H2S donors inhibits 
visceral nociception by opening KATP channels. The activation of KATP channels in the peripheral 
nociceptive system has been seen to be involved in the modulation of nociception.    Additional 
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targets such as voltage-dependent Ca2+ channels, Ca2+-dependent K+ channels and ill-defined 
endothelium-dependent mechanisms appear to play a minor role in H2S induced vasodilation.  
Generalization of these inhibitory mechanisms to other smooth muscle is problematic.  The 
mechanism of inhibition of contraction by H2S appears to be species- and tissue-specific, and 
varies with activation of the muscle.  Inhibition of contraction by NaHS in urinary bladder was 
abolished by capsaicin suggesting the involvement of TRPV1 receptors.  Glibenclamide 
insensitive effect of NaHS was also observed in mouse aorta, mouse bronchial rings, and mouse 
gastric fundus and guinea pig ileum.149 150 However, inhibition of spontaneous contractions by 
NaHS in human and rat colon were affected by glibenclamide and apamin.  In these nerve-
muscle preparation, H2S may also affect enteric neurons to regulate smooth muscle function.  A 
direct effect on muscle was implicated in distal colon of mouse and human since the Na+ channel 
blocker tetradotoxin had no effect on the relaxation. However, an effect on interstitial cells of 
Cajal would also influence the function of smooth muscle in these preparations.   
Although, exogenous NaHS has potent inhibitory effect on muscle contraction both in 
muscle strip preparations and isolated muscle cells, it was demonstrated that luminal application 
of NaHS was less effective than in isolated strips.151 This could be due to effective barrier 
function of mucosa to limit the diffusion of H2S to the muscle layers and efficient metabolism of 
H2S to thiosulfate and sulphate by colonic mucosa.  In humans and mice, H2S can be produced 
upto 1mM range in the GI tract and efficient oxidation process by sulphide quinine 
oxidoreductase, sulphur dioxygenase and rhodanese would offer protection against high local 
concentrations.152 Damage to this protective mucosal barrier function, as in the ulcerative colitis, 
may lead to increased access of H2S to the inner muscle layers of GI tract.  
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Use of innervated muscle strips, isolated muscle strips limits the interpretation about the 
precise site of H2S synthesis and its action. In the present study, using dispersed muscle cells and 
using activator of CSE and H2S donor, we showed that H2S inhibits CCh-induced sustained 
contraction.  Evidence for the activation of CSE in mediating the effect of L-cysteine was based 
on selective expression of CSE in muscle cells. These results also strongly suggest that 
endogenous H2S may be responsible for the L-cysteine–induced relaxation seen in our 
experiments. We carried out further experiments in dispersed muscle cells to investigate the 
mechanism of action of H2S to mediate relaxation of sustained contraction.  Our studies 
demonstrated that the inhibition of contraction is mediated via inhibition of CCh-induced Rho 
kinase activity.  Evidence for this conclusion was based on inhibition of CCh-induce Rho kinase 
activity by both endogenous and exogenous H2S and blockade of sustained contraction by 
Y27632, a selective Rho kinase inhibitor.  Further evidence was provided using CSE siRNA.  
Suppression of CSE expression blocked the inhibitory effect of L-cysteine on Rho kinase 
activity.  Glibenclamide, a selective inhibitor of KATP channels and a well-characterized target of 
H2S to mediate muscle relaxation, had no effect on inhibition of contraction by L-cysteine or 
NaHS.  
Previous studies have demonstrated that relaxation of RhoA/Rho kinase-mediated 
contraction by PKA and PKG involves phosphorylation of RhoA at Ser188 and inhibition of its 
ability to activate Rho kinase, phosphorylation of MYPT1 at Ser695 and blockade of inhibitory 
phosphorylation at the adjacent Thr696 by Rho kinase, and/or phosphorylation of telokin at Ser13, 
an endogenous MLC phosphatase stimulator.153 154 We examined whether H2S mediated 
inhibition of Rho kinase activity and contraction involves cAMP- and/or cGMP-dependent 
mechanisms.  Studies also showed that L-cysteine or NaHS had no effect on cAMP levels and 
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the effect of H2S on contraction was not affected in the presence of PKA or PKG inhibitors.  
Similarly, inhibition of contraction by NaHS in mouse distal colon strips was not affected by NO 
synthase inhibitor, L-NAME, sGC inhibitor, ODQ, or SQ22536, adenylyl cyclise inhibitor 
observed in mouse distal colon strips.155 These results suggest that the relaxation by H2S was 
mediated via a distinct mechanism independent of cAMP/PKA and cGMP/PKG pathways. H2S 
act via protein sulfhydration to regulate various physiological functions.  Future studies involve 
measurement of S-sulfhydration of Rho kinase or upstream targets such RhoA in response to L-
cysteine or NaHS.  S-sulfhydration provides a possible mechanism by which H2S alters the 
function of several proteins and this process appears to common posttranslational modification 
and analogous to S-nitrosylation of proteins by NO.  In this process, a hydropersulfide (-SSH) 
moiety is generated by the addition of sulphur from H2S to the –SH groups of cysteine residues 
and this results in altered chemical and biological reactivity of proteins. Snyder and colleagues 
have shown loss of protein sulfhydration in CSE-/- mice compared to proteins in control mice.156 
The covalent modification of proteins by sulfhydration is a well characterized mechanism, but 
the physiological mechanism in the reversal of sulfhydration is not clear.  Sulfhydration is 
reversed by reducing agents such as dithiothreitol.   
In summary, our studies have demonstrated that both exogenous and endogenous H2S 
inhibits agonist-induced sustained muscle contraction in the stomach, and the inhibitory effect is 
mediated via inhibition of Rho kinase activity, a key enzyme in the regulation of MLC 
phosphatase activity and sustained muscle contraction. Inhibition of Rho kinase activity and 
ensuing disinhibition of MLC phosphatase activity leads to MLC20 dephosphorylation, a 
prerequisite for muscle relaxation (Fig 15). The extent to which endogenous H2S contributes to 
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smooth muscle tone and gastrointestinal motility under physiological conditions, and the 
physiological mechanism that regulate CSE activity and H2S generation awaits further research.     
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Figure 15: Scheme depicting the pathways involved in the regulation of MLC20 
phosphorylation and muscle contraction in smooth muscle. MLC20 Phosphorylation in 
response to contractile agonists is initiated by stimulation of Ca2+ calmodulin-dependent MLC 
kinase and sustained by inhibition of MLC phosphatase activity via Rho kinase-dependent 
phosphorylation of MLC phosphatase regulatory subunit. H2S inhibits Rho kinase activity 
leading to stimulation of MLC phosphatase activity, MLC20 dephosphorylation and muscle 
relaxation.  
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Figure 15 
 
 
 
 
 
 
 
77 
 
 
E. REFERENCES 
 
1 Wang, Rui. Physiological explorations of Hydrogen sulfide: A whiff exploration that 
blossomed. Physiological reviews, Vol.92 (2), pp.791-896, 2012 
 
2 Wang R. Toxic gas lifesaver. Sci Am 302: 66–71, 2010. 
 
3 Hooper DG, Shane J, Straus DC, Kilburn KH, Bolton V, Sutton JS, Guilford FT. Isolation of 
sulfur reducing bacteria and oxidizing bacteria found in contaminated drywall. Int J Mol Sci 11: 
647–55, 2010. 
 
4 Leustek T, Martin MN, Bick J, Davies JP. Pathways and regulation of sulfur metabolism 
revealed through molecular genetic studies. Annu Rev Plant Physiol Plant Mol Biol 51: 141–
166, 2000. 
 
5 Julian D, Statile JL, Wohlgemuth SE, Arp AJ. Enzymatic hydrogen sulfide production in 
marine invertebrate tissues. Comp Biochem Physiol A Physiol 133: 105–115, 2002. 
 
6 Julian D, Statile J, Roepke TA, Arp AJ. Sodium nitroprusside potentiates hydrogen sulfide- 
induced contractions in body wall muscle from a marine worm. Biol Bull 209: 6–10, 2005. 
 
7 Goodwin LR, Francom D, Dieken FP, Taylor JD, Warenycia NW, Reiffenstein RJ, Dowling G. 
Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies 
and two case reports. J Anal Toxicol 13: 105–109, 1989. 
 
8 Braunstein AE, Goryachenkova EV, Lac ND. Reactions catalyzed by serine sulfhydrase from 
chicken liver. Biochem Biophys Acta 171: 366–368, 1969. 
 
9 Porter PN, Grishaver MS, Jones OW. Characterization of human cystathionine betasynthase. 
Evidence for the identity of human L-serine dehydratase and cystathionine beta-synthase. 
Biochem Biophys Acta 364: 128–139, 1974. 
 
10 Stepién PP, Pieniazek NJ. The use of the L-serine sulfhydrylase assay for the estimation of 
cystathionine beta-synthase. Anal Biochem 54: 294–299, 1973. 
 
11 Allsop J, Watts RW. Methionine adenosyltransferase, cystathionine beta-synthase and 
cystathionine gamma-lyase activity of rat liver subcellular particles, human blood cells and 
mixed white cells from rat bone marrow. Clin Sci Mol Med Suppl 48: 509–513, 1975. 
 
12 Radcliffe BC, Egan AR. A survey of methionine adenosyltransferase and cystathionine 
gamma-lyase activities in ruminant tissues. Aust J Biol Sci 27: 465–471, 1974. 
 
13 Yao K. Effects of several unusual sulfur-containing amino acids on rat liver cystathionine- 
gamma-lyase. Physiol Chem Phys 7: 401–408, 1975. 
 
 
78 
 
 
14 Fiedler H, Wood JL. Specificity studies on the beta-mercaptopyruvate-cyanide transsulfuration 
system. J Biol Chem 222: 387–397, 1956. 
 
15 Shen X, Pattillo CB, Pardue S, Bir SC, Wang R, Kevil CG. Measurement of plasma hydrogen 
sulfide in vivo and in vitro. Free Radic Biol Med 50: 1021–1031, 2011. 
 
16 Kruszyna H, Kruszyna R, Smith RP. Cyanide and sulfide interact with nitrogenous compounds 
to influence the relaxation of various smooth muscles. Proc Soc Exp Biol 
Med 179: 44–49, 1985. 
 
17 Kombian SB, Reiffenstein RJ, Colmers WF. The actions of hydrogen sulfide on dorsal raphe 
serotonergic neurons in vitro. J Neurophysiol 70: 81–96, 1993. 
 
18 Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J 
Neurosci 16: 1066–1071, 1996. 
 
19 Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous 
smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Comm 237: 527 531, 
1997. 
 
20 Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect ofH2S as a novel endogenous 
gaseous KATP channel opener. EMBO J 20: 6008–6016, 2001. 
 
21 Jhee KH, Kruger WD. The role of cystathionine beta-synthase in homocysteine metabolism. 
Antioxid Redox Signal 7: 813–822, 2005. 
 
22 Cantoni GL. The nature of the active methyl donor formed enzymatically from L-methionine 
and adenosine triphosphate. J Am Chem Soc 74: 2942–2943, 1952. 
 
23 Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of 
homocysteine and cysteine. Annu Rev Nutr 24: 539–577, 2004. 
 
24 Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine- beta-
synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys 433: 144–156, 2005. 
 
25 Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J 
Neurosci 16: 1066–1071, 1996. 
 
26 Wang J, Dudman NP, Wilcken DE, Lynch JF. Homocysteine catabolism: levels of 3 enzymes 
in cultured human vascular endothelium and their relevance to vascular disease. Atherosclerosis 
97: 97–106, 1992. 
 
27 Jhee KH, Kruger WD. The role of cystathionine beta-synthase in homocysteine metabolism. 
Antioxid Redox Signal 7: 813–822, 2005. 
 
 
79 
 
 
28 Kabil O, Zhou Y, Banerjee R. Human cystathionine beta-synthase is a target for sumoylation. 
Biochemistry 45: 13528–13536, 2006. 
 
29 Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, 
Graf EE, Upson B. Polymorphisms in the CBS gene associated with decreased risk of coronary 
artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol 
Genet Metab 70: 53–60, 2000. 
 
30 Eto K, Kimura H. The production of hydrogen sulfide is regulated by testosterone and S-
adenosyl-L-methionine in mouse brain. J Neurochem 83: 80–86, 2002. 
 
31 Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, Brosnan JT. Hormonal regulation 
of cystathionine beta-synthase expression in liver. J Biol Chem 277: 42912– 42918, 2002. 
 
32 Enokido Y, Suzuki E, Iwasawa K, Namekata K, Okazawa H, Kimura H. Cystathionine beta-
synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial 
glia/astrocyte lineage of developing mouse CNS. FASEB J 19: 1854–1856, 2005. 
 
33 Cunha TM, Dal-Secco D, VerriWAJr, Guerrero AT, Souza GR, Vieira SM, Lotufo CM, Neto 
AF, Ferreira SH, Cunha FQ. Dual role of hydrogen sulfide in mechanical inflammatory 
hypernociception. Eur J Pharmacol 590: 127–135, 2008. 
 
34 Bordo D, Bork P. The rhodanese/C25 phosphatase superfamily. Sequence-structure function 
relations. EMBO Rep 3: 741–746, 2002. 
 
35 Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous 
smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Comm 237: 527–
531, 1997. 
 
36 Yang G, Sun X, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle 
cells via the activation of mitogen activated protein kinases and caspase-3. FASEB J 18: 1782–
1784, 2004. 
 
37 Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R, Renga B, 
Di Sante M, Morelli A. Inhibition of hydrogen sulfide generation contributes to gastric injury 
caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129: 1210–1224, 2005. 
 
38 Erickson PF, Maxwell IH, Su LJ, Baumann M, Glode LM. Sequence of cDNA for rat 
cystathionine gamma-lyase and comparison of deduced amino acid sequence with related 
Escherichia coli enzymes. Biochem J 269: 335–340, 1990. 
 
39 Steegborn C, Clausen T, Sondermann P, Jacob U, Worbs M, Marinkovic S, Rand H, Wahl 
MC. Kinetics and inhibition of recombinant human cystathionine-g-lyase: toward the rational 
control of transsulfuration. J Biol Chem 274: 12675–12684, 1999. 
 
80 
 
 
 
40 Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect ofH2S as a novel endogenous 
gaseous KATP channel opener. EMBO J 20: 6008–6016, 2001. 
 
41 Ishii I, Akahoshi N, Yu XN, Kobayashi Y, Namekata K, Komaki G, Kimura H. Murine 
cystathionine _-lyase: complete cDNA and genomic sequences, promoter activity, tissue 
distribution and developmental expression. Biochem J 381: 113–123, 2004. 
 
42 Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5: 493– 501, 
2003. 
 
43 Awata S, Nakayama K, Sato A, Kawamura M, Suzuki I, Kodama H. Changes in cystathionine- 
g-lyase levels in rat liver during lactation. Biochem Mol Biol Int 31: 185–191, 1993. 
 
44 Sato A, Nishioka M, Awata S, Nakayama K, Okada M, Horiuchi S, Okabe N, Sassa T, Oka T, 
Natori Y. Vitamin B6 deficiency accelerates metabolic turnover of cystathionase in rat liver. 
Arch Biochem Biophys 330: 409–413, 1996. 
 
45 Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Maraziotia A, Zhouc Z, Jeschked MG, 
Branskid LK, Herndond DN, Wang R, Szabo C. Hydrogen sulfide is an endogenous stimulator 
of angiogenesis. Proc Natl Acad Sci USA 106: 21972–21977, 2009. 
 
46 Bucci M, Mirone V, Di Lorenzo A, Vellecco V, Roviezzo F, Brancaleone V, Ciro I, Cirino G. 
Hydrogen sulfide is involved in testosterone vascular effect. Eur Urol 5: 378–384, 2009.  
 
47 Renga B. Hydrogen sulfide generation in mammals: the molecular biology of cystathionine-g-
synthase (CBS) and cystathionine-_-lyase (CSE). Inflamm Allergy Drug Targets 10: 85–91, 
2011.  
 
48 Spallarossa A, Forlani F, Carpen A, Armirotti A, Pagani S, Bolognesi M, Bordo D. The 
“rhodanese” fold and catalytic mechanism of 3-mercaptopyruvate sulfurtransferases: crystal 
structure of SseA from Escherichia coli. J Mol Biol 335: 583–593, 2004. 
 
49 Chatagner F, Sauret-Ignazi G. Role of transamination and pyridoxal phosphate in the 
enzymatic formation of hydrogen sulfide from cysteine by the rat liver under anaerobiosis. Bull 
Soc Chim Biol 38: 415–428, 1956. 
 
50 Kuo SM, Lea TC, Stipanuk MH. Developmental pattern, tissue distribution, and subcellular 
distribution of cysteine: Alpha-ketoglutarate aminotransferase and 3-mercaptopyruvate 
sulfurtransferase activities in the rat. Biol Neonate 43: 23–32, 1983. 
 
51 Flavin M, Slaughter C. Enzymatic synthesis of homocysteine or methionine directly from o-
succinyl-homoserine. Biochem Biophy Acta Enzymol 132: 400–405, 1967. 
 
 
81 
 
 
52 Insko MA, Deckwerth TL, Hill P, Toombs CF, Szabo C. Detection of exhaled hydrogen 
sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol 157: 944–951, 
2009. 
 
53 Caliendo G, Cirino G, Santagada V, Wallace JL. Synthesis and biological effects of hydrogen 
sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J Med Chem 53: 6275–
6286, 2010. 
 
54 Picton R, Eggo MC, Merrill GA, Langman MJ, Singh S. Mucosal protection against sulphide: 
importance of the enzyme rhodanese. Gut 50: 201–205, 2002. 
 
55 Weisiger RA, Pinkus LM, Jacoby WB. Thiol S-methyltransferase: suggested role in 
detoxification of intestinal hydrogen sulfide. Biochem Pharmacol 29: 2885–2887, 1980. 
 
56 Beauchamp RO Jr, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the 
literature on hydrogen sulfide toxicity. Crit Rev Toxicol 13: 25–97, 1984. 
 
57Pasquale et al. Physiological and pharmacological features of the novel gasotransmitter: 
Hydrogen sulfide. BBA - Bioenergetics, Vol.1787(7), pp.864-872. 2009 
 
58Kimura et al. Physiological Roles of Hydrogen Sulfide: Synaptic Modulation, Neuroprotection, 
and Smooth Muscle Relaxation. Antioxidants & Redox Signaling. 7(5-6): 795-803, 2006 
 
59 Feletou M, Vanhoute PM. Endothelium-dependent hyperpolarization of canine coronary 
smooth muscle. Br J Pharmacol 93: 515–524, 1988. 
 
60 Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG. Vasorelaxant properties of the 
endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. 
Nature 345: 161–163, 1990. 
 
61 Suematsu M, Goda N, Sano T, Kashiwagi S, Egawa T, Shinoda Y, Ishimura Y. Carbon 
monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest 96: 
2431–2437, 1995. 
 
62 Cheng Y, Ndisang JF, Tang G, Cao K, Wang R. Hydrogen sulfide-induced relaxation of 
resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287: H2316– H2323, 
2004. 
 
63 Leffler CW, Parfenova H, Basuroy S, Jaggar JH, Umstot ES, Fedinec AL. Hydrogen sulfide 
and cerebral microvascular tone in newborn pigs. Am J Physiol Heart Circ Physiol 300: H440–
H447, 2011. 
 
64 Zhao W, Ndisang JF, Wang R. The modulation of endogenous production of H2S in rat tissues. 
Can J Physiol Pharmacol 81: 848–853, 2003. 
 
 
82 
 
 
65 Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, 
Snyder SH, Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of 
cystathionine gamma-lyase. Science 322: 587–590, 2008. 
 
66 Lake-Bruse KD, Faraci FM, Shesely EG, Maeda N, Sigmund CD, Heistad DD. Gene transfer 
of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol Heart Circ 
Physiol 277: H770–H776, 1999. 
 
67 Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13–19, 2002. 
 
68 Enokido Y, Suzuki E, Iwasawa K, Namekata K, Okazawa H, Kimura H. Cystathionine beta 
synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial 
glia/astrocyte lineage of developing mouse CNS. FASEB J 19: 1854–1856, 2005. 
 
69 Ichinohe A, Kanaumi T, Takashima S, Enokido Y, Nagai Y, Kimura H. Cystathionine beta-
synthase is enriched in the brains of Down’s patients. Biochem Biophys Res Commun 338: 
1547–1550, 2005. 
 
70 Leffler CW, Parfenova H, Basuroy S, Jaggar JH, Umstot ES, Fedinec AL. Hydrogen sulfide 
and cerebral microvascular tone in newborn pigs. Am J Physiol Heart Circ Physiol 300: H440–
H447, 2011. 
 
71 Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. 
Pharmacol Rev 51: 7–61, 1999. 
 
72 Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13–19, 2002. 
 
73 Tyagi N, Moshal KS, Sen U, Vacek TP, Kumar M, Hughes WM Jr, Kundu S, Tyagi SC. H2S 
protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid Redox 
Signal 11: 25–33, 2009. 
 
74 Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, Thiemermann C. Inhibition of 
endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J 
Pharmacol 146: 498–505, 2005. 
 
75 Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-
Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide- induced 
inflammation in the mouse. FASEB J 19: 1196–1198, 2005. 
 
76 Tamizhselvi R, Moore PK, Bhatia M. Inhibition of hydrogen sulfide synthesis attenuates 
chemokine production and protects mice against acute pancreatitis and associated lung injury. 
Pancreas 36: e24–e31, 2008. 
 
77 Zhang H, Bhatia M. Hydrogen sulfide: a novel mediator of leukocyte activation. 
Immunopharmacol Immunotoxicol 1: 1–15, 2008. 
 
83 
 
 
 
78 Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, 
Szabó C, Kimura H, Chow CW, Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-
reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 
15560–15565, 2007. 
 
79 Esechie A, Kiss L, Olah G, Horvath EM, Hawkins H, Szabó C, Traber DL. Protective effect of 
hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke 
inhalation. Clin Sci 115: 91–97, 2008. 
 
80 Hu LF, Wong PT, Moore PK, Bian JS. Hydrogen sulfide attenuates lipopolysaccharide 
induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. 
J Neurochem 100: 1121–1128, 2007. 
 
81 Li T, Zhao B, Wang C, Wang H, Liu Z, Li W, Jin H, Tang CS, Du J. Regulatory effects of 
hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with 
acute lung injury. Exp Biol Med 233: 1081–1087, 2008. 
 
82 Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi 
R, Thiemermann C. Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat 
model of regional myocardial I/R. Shock 31: 267–274, 2009. 
 
83 Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-
Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide- induced 
inflammation in the mouse. FASEB J 19: 1196–1198, 2005. 
 
84 Mariggio MA, Minunno V, Riccardi S, Santacroce R, De Rinaldis P, Fumarulo R. Sulfide 
enhancement of PMN apoptosis. Immunopharmacol Immunotoxicol 20: 399–408, 1988. 
 
85 Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide 
is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 2118–2120, 
2006. 
 
86 Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide 
is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 2118–2120, 
2006. 
 
87 Rojo LE, Fernández JA, Maccioni AA, Jimenez JM, Maccioni RB. Neuroinflammation: 
implications for the pathogenesis and molecular diagnosis of Alzheimer’s disease. Arch Med Res 
39: 1–16, 2008. 
 
88 Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, Chung 
HT. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme 
oxygenase-1 expression in RAW2647 macrophages stimulated with lipopolysaccharide. Free 
Radical Biol Med 41: 106–119, 2006. 
 
84 
 
 
 
89 Qingyou Z, Junbao D, Weijin Z, Hui Y, Chaoshu T, Chunyu Z. Impact of hydrogen sulfide on 
carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary 
hypertension. Biochem Biophys Res Commun 317: 30–37, 2004. 
 
90 Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to 
therapeutic applications. Physiol Rev 86: 583–650, 2006. 
 
91 Bhatia M, Sidhapuriwala J, Moochhala SM, Moore PK. Hydrogen sulfide is a mediator of 
carrageenan-induced hindpaw oedema in the rat. Br J Pharmacol 145: 141–144, 2005. 
 
92 Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in 
acute pancreatitis and associated lung injury. FASEB J 19: 623–625, 2005. 
 
93 Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-
Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide- induced 
inflammation in the mouse. FASEB J 19: 1196–1198, 2005. 
 
94 Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic responses to infusion 
of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J 
Pharmacol 128: 1772–1778, 1999. 
 
95 Hui Y, Du J, Tang C, Bin G, Jiang H. Changes in arterial hydrogen sulfide (H2S) content 
during septic shock and endotoxic shock in rats. J Infect 47: 155–160, 2003. 
 
96Zhang H, Bhatia M. Hydrogen sulfide: a novel mediator of leukocyte activation. 
Immunopharmacol Immunotoxicol 1: 1–15, 2008. 
 
97 Zhi L, Ang AD, Zhang H, Moore PK, Bhatia M. Hydrogen sulfide induces the synthesis of 
proinflammatory cytokines in human monocyte cell line U937 via the ERK-NFkappaB pathway. 
J Leukoc Biol 81: 1322–1332, 2007. 
 
98 Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, 
Solomon H. H2S signals through protein S-sulfhydration. Sci Signal 2: ra72, 2009. 
 
99 Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-
nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active 
compounds. Proc Natl Acad Sci USA 89: 444–448, 1992. 
 
100 Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, 
Solomon H. H2S signals through protein S-sulfhydration. Sci Signal 2: ra72, 2009. 
 
101 Cheng Y, Ndisang JF, Tang G, Cao K, Wang R. Hydrogen sulfide-induced relaxation of 
resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287: H2316– H2323, 
2004. 
 
85 
 
 
 
102 Tang G, Wu L, Liang W, Wang R. Direct stimulation of KATP channels by exogenous and 
endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 68: 1757–1764, 
2005. 
 
103 Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, Armstrong JS, Moore PK. 
Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the 
brain. Biochem Biophy Res Commun 326: 794–798, 2005. 
 
104 Whiteman M, Armstrong JS, Chu SH, Siau JL, Wong BS, Cheung NS, Halliwell B, Moore 
PK. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite “scavenger”? J 
Neurochem 90: 765–768, 2004. 
 
105 Wagner F, Asfar P, Calzia E, Radermacher P, Szabó C. Bench-to-bedside review. Hydrogen 
sulfide–the third gaseous transmitter: applications for critical care. Crit Care 13: 213, 2009. 
 
106 Chen YH, Yao WZ, Geng B, Ding YL, Lu M, Zhao MW, Tang CS. Endogenous hydrogen 
sulfide in patients with COPD. Chest 128: 3205–3211, 2005. 
 
107 Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Russo G, Caliendo G, Santagada V, 
Cirino G, Wallace JL, Fiorucci S. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-
3yl)-phenyl ester (ATB-429), a hydrogen sulfidereleasing derivative of mesalamine, exerts 
antinociceptive effects in a model of postinflammatory hypersensitivity. J Pharmacol Exp Ther 
319: 447–458, 2006. 
 
108 Martin GR, McKnight GW, Dicay MS, Coffin CS, Ferraz JG, Wallace JL. Hydrogen sulfide 
synthesis in the rat and mouse gastrointestinal tract. Dig Liver Dis 42: 103–109, 2010. 
 
109 Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous 
smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Comm 237: 527–
531, 1997. 
 
110 Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, Zanardo R, Renga B, 
Di Sante M, Morelli A. Inhibition of hydrogen sulfide generation contributes to gastric injury 
caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129: 1210–1224, 2005. 
 
111 Zhao W, Ndisang JF, Wang R. The modulation of endogenous production of H2S in rat 
tissues. Can J Physiol Pharmacol 81: 848–853, 2003. 
 
112 Srebro Z, Somogyi E, Wilinski B, Goralska M, Wilinski J, Sura P. Aspirin augments the 
concentration of endogenous hydrogen sulfide in mouse brain and liver. Folia Med Cracov 47: 
87–91, 2006. 
 
 
86 
 
 
113 Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous 
smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Comm 237: 527–
531, 1997. 
 
114 Zhao P, Huang X, Wang ZY, Qiu ZX, Han YF, Lu HL, Kim YC, Xu WX. Dual effect of 
exogenous hydrogen sulfide on the spontaneous contraction of gastric smooth muscle in guinea 
pig. Eur J Pharmacol 616: 223–228, 2009. 
 
115 Fiorucci S, Santucci L, Distrutti E. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: 
what lies beyond the horizon. Dig Liver Dis 39: 1043–1051, 2007. 
 
116 Webb R Clinton. Smooth muscle contraction and relaxation. Adv Physiol EducDecember 
1, vol. 27 no. 4 201-206, 2003 
 
117 Hartshorne DJ. Biochemistry of the contractile process in smooth muscle. In: Johnson LR, ed. 
Physiology of the Gastrointestinal Tract. New York, NY: Raven Press; 432–482, 1987 
 
118 Murthy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annual 
Review of Physiology, Vol. 68: 345 -374 
119 Sandow A (1952). Excitation-Contraction Coupling in Muscular Response. Yale J Biol 
Med 25 (3): 176–201 
120 Frank V. Brozovich. Agonist Stimulation and Depolarization Come Together. Circulation 
Research.2003; 93; 481-483 
121 Chirag A. Patel. Spontaneously tonic smooth muscle has characteristically higher levels of 
RhoA/ROK compared with the phasic smooth muscle. AJP - Gastrointestinal and Liver 
Physiology , Volume 291 (5): G830  
 
122 Tetsuya Seko et al. Activation of RhoA and Inhibition of Myosin Phosphatase as Important 
Components in Hypertension in Vascular Smooth Muscle. Circulation Research; 92; 411-418, 
2003 
 
123 Murthy KS. Modulation of soluble guanylate cyclase activity by phosphorylation. Neurochem 
Int;45:845–851, 2004 
 
124 J.R.Grider Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement 
of VIP release. AJP - GI April 1, vol. 262 no. 4 G774-G778, 1992 
 
125 Murthy KS. Inhibition of sustained smooth muscle contraction by PKA and PKG 
preferentially mediated by phosphorylation of RhoA. Am J Physiol Gastrointest Liver Physiol.  
Jun;284(6):G1006-16, 2003 
 
 
87 
 
 
126 R. Clinton Webb. Smooth muscle contraction and relaxation. Adv Physiol Educ. December 
1, vol. 27 no. 4 201-206, 2003 
 
127 Ryan A. Dombkowski. Hydrogen sulfide (H2S) and hypoxia inhibit salmonid gastrointestinal 
motility: evidence for H2S as an oxygen sensor. The Journal of Experimental Biology 214, 4030-
4040. Annual Review of Pharmacology and Toxicology. Vol. 51: 169-18 
 
128 David R Linden et al. Endogenous Production of H2S in the Gastrointestinal Tract: Still in 
Search of a Physiologic Function. Antioxid Redox Signal. 2010 May 1; 12(9): 1135–1146. 
 
129 C Zoccali. Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. 
Nephrol Dial Transplant (2009) 
 
130 Jeffrey R. Koenitzer. Hydrogen sulfide mediates vasoactivity in an O2-dependent manner. 
AJP - Heart April vol. 292 no. 4 H1953-H1960, 2007 
 
131 B Hennig et al. Actions of hydrogen sulphide on ion transport across rat distal colon Br J 
Pharmacol. November; 158(5): 1263–1275, 2009 
 
132 B Teague. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a 
physiological role to control intestinal contractility. Br J Pharmacol. September; 137(2): 139–
145, 2002 
 
133 Parajuli SP et al. The Inhibitory Effects of Hydrogen Sulfide on Pacemaker Activity of 
Interstitial Cells of Cajal from Mouse Small Intestine. Korean J Physiol Pharmacol. April; 14(2): 
83–89, 2010 
 
134 Murthy KS et al. Sustained muscle contraction induced by agonists, growth factors and Ca2+ 
mediated by distinct PKC isozymes. Am J Physiol; Gastrointest Liver Physiol 279: G201-G210, 
2000. 
 
135 Murthy KS et al. Inhibition of sustained smooth muscle contraction by PKA and PKG 
preferentially mediated by phosphorylation of RhoA. Am J Physiol; Gastrointest Liver physiol 
284: G1006-G1016, 2003b. 
 
136 Murthy KS et al. Sequential activation of heterotrimeric and monomeric G proteins mediates 
PLD activity in smooth muscle. Am J Physiol; Gastrointest Liver Physiol 280: G381-G388, 
2001. 
 
137 Murthy KS et al. Differential signalling by muscarinic receptors in smooth muscle: m2-
mediated inactivation of myosin light chain kinase via Gi3, cdc42/Rac1 and p21-activated kinase 
1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) 
phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protien 
kinase C/CPI-17 pathway. Biochem J  374: 145-155, 2003a. 
 
 
88 
 
 
138 Teng et al, Expression of endothelial nitric oxide synthase in human and rabbit 
gastrointestinal smooth muscle cells. Am J Physiol; 275(2 Pt 1): G342-51, 1998 Aug 
 
139 Distrutti E et al, Evidence that Hydrogen Sulfide exerts antinociceptive effects in the 
Gastrointestinal tract by Activating Katp channels. Journal of Pharmacology and experimental 
and experimental therapies JPET 316:325–335, 2006 
 
140  Grider et al, Enteric motor and interneuronal circuits controlling motility. Neurogastroentrol 
Motil; 16 Suppl 1: 34-8, 2004 Apr 
 
141 Tang G et al. Direct Stimulation of KATP Channels by Exogenous and Endogenous Hydrogen 
Sulfide in Vascular Smooth Muscle Cells. Molecular Pharmacology vol. 68 no. 6 1757-1764, 
2008  
 
142Rui Wang. Antioxidants & Redox Signaling., 5(4): 493-501. August 2003 
143 Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of 
neurotransmission in the gastrointestinal tract Gastroenterology;111(2):492-515, 1996 Aug 
 
144 Deplancke B. Gastrointestinal and Microbial Responses to Sulfate-Supplemented Drinking 
Water in Mice. Exp Biol Med vol. 228 no. 4 424-433, April 2003  
 
145John L. Wallace, Hydrogen sulfide-releasing anti-inflammatory drugs, Trends in 
Pharmacological Sciences, Volume 28, Issue 10, Pages 501-505, October 2007 
146Wang R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous 
transmitter. The FASEB Journalvol. 16 no. 13 1792-1798 
147Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K et al. H2S as a physiologic vasorelaxant: 
hypertension in mice with deletion of cystathionine gamma-lyase; 322: 587 –590, Science 2008 
148Zhao W et al. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel 
opener; 20(21): 6008–6016, EMBO J. 2001 November 1 
149Kubo S et al. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide 
synthase. Toxicology 20;241(1-2):92-7. Epub Aug 19 2007 . 
150Dhaese et al. Mechanisms of action of Hydrogen sulphide in relaxation of mouse distal 
colonic smooth muscle. Eur J Pharmacol; 628(1-3):179-86, 2010 Feb 25 
151Gallego D et al. The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in 
the human, rat and mouse colon and jejunum. Neurogastroenterology & Motility Volume 
20, Issue 12, pages 1306–1316, December 2008 
 
89 
 
 
152Deplancke B et al. Gastrointestinal and Microbial Responses to Sulfate-Supplemented 
Drinking Water in Mice. Exp Biol Med vol. 228 no. 4 424-433, April 2003  
153 Murthy KS. Signalling for contraction and relaxation in smooth muscle of the gut. Annual 
Review of Physiology, Vol. 68: 345 -374 
154Murthy KS. Inhibition of sustained smooth muscle contraction by PKA and PKG 
preferentially mediated by phosphorylation of RhoA. Am J Physiol Gastrointest Liver 
Physiol.;284(6):G1006-16, 2003 Jun 
155Dhaese et al. Mechanisms of action of Hydrogen sulphide in relaxation of mouse distal 
colonic smooth muscle. Eur J Pharmacol; 628(1-3):179-86, Feb 2010  
156Gadalla and Synder. Hydrogen sulfide as a gasotransmitter. J Neurochem. Apr;113(1):14-26, 
2010.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
 
Vita 
 
Ancy D. Nalli was born on September 19th 1989. She received her Bachelor’s degree in 
Biotechnology (2010) and Post Graduate Diploma in Bioinformatics (2011) from Osmania 
University, India. She then entered Graduate School at Virginia Commonwealth University, 
School of Medicine in 2011. She is a member of the American Physiological Society.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
